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Rationale: Delirium is a serious, morbid condition affecting 2.6 million older 
Americans annually. A major problem plaguing delirium research is difficulty in 
identification, given a plethora of existing tools. The lack of consensus on key 
features and approaches has stymied progress in delirium research. The goal of 
this project was to use advanced measurement methods to improve delirium’s 
identification. 
 
Aims and Findings: 
(1) Determine the 4 most commonly used and well-validated instruments for 
delirium identification. Through a rigorous systematic review, I identified the 
Confusion Assessment Method (CAM), Delirium Observation Screening Scale 
(DOSS), Delirium Rating Scale-Revised-98 (DRS-R-98), and Memorial 
Delirium Assessment Scale (MDAS). 
(2) Harmonize the 4 instruments to generate a delirium item bank (DEL-IB), a 
dataset containing items and estimates of their population level parameters. 
In a secondary analysis of 3 datasets, I equated instruments on a common 
metric and created crosswalks. 
(3) Explore applications of the harmonized item bank through several 
approaches. First, identifying different cut-points that will optimize: (a) 
balanced high accuracy (Youden’s J-Statistic), (b) screening (sensitivity), and 
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(c) confirmation of diagnosis (specificity) in identification of delirium. Second, 
comparing performance characteristics of example forms developed from the 
DEL-IB. 
 
Impact: The knowledge gained includes harmonization of 4 instruments for 
identification of delirium, with crosswalks on a common metric. This will pave the 
way for combining studies, such as meta-analyses of new treatments, essential 
for developing guidelines and advancing clinical care. Additionally, the DEL-IB 
will facilitate creating big datasets, such as for omics studies to advance 
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CHAPTER I – Introduction 
 
Why Measurement is Important 
A key facet of evidence-based medicine is the generation of new scientific 
evidence. The derivation of this evidence originates from direct observations and 
empirical research studies. A key component of these empirical research studies 
is translating clinical observations into data that one can use to compare groups, 
evaluate treatments, or elucidate clinical outcomes. Generally, this numerical 
data requires the use of measurement instruments. The science behind 
measurement informs the optimal construction and character of measurement 
instruments for specific purposes and in specific contexts. For example, even 
before testing in a study population, careful thought must be given to the 
instrument design in terms of who would administer the instrument (e.g., 
physicians, nurses, trained researchers), in what clinical context (e.g., medical or 
surgical wards, emergency department, intensive care unit (ICU)), and for what 
purpose (e.g., screening, diagnosing, severity rating). Optimizing measurement is 
important because it maximizes the accuracy of instruments and their efficient 
application, that is, allowing for the best use of limited clinical resources in the 





Measurement is foundational to the field of delirium. Delirium, an acute change in 
cognition, characterized by a waxing and waning course with multiple cognitive 
impairments including inattention and disorientation, is still a clinical diagnosis 
without known laboratory tests or biomarkers. Thus, the measurement of delirium 
must inform all clinical and research developments in the field to assure decision-
making is accurate and evidence-based. The field of delirium provides useful 
examples of how measurement must progress and adapt over time. The 
Confusion Assessment Method (CAM), developed in 1990, was one of the first 
measurements of delirium diagnosis (1). As the field has progressed, new and 
adapted measures have developed to serve new uses. For example, the 
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) (2, 3) was 
developed to measure delirium in the ICU setting and the CAM-S (4) was 
devised to accurately measure delirium severity. 
 
 
Clinical Overview of Delirium 
Delirium is an important yet under-recognized syndrome characterized by acute 
onset, inattention along with other cognitive impairments, and a waxing and waning 
course. Accounts of delirium date back several millennia (5) and was first used as 
a medical term in the first century AD, characterizing mental syndromes following 
head trauma or fever (6, 7). Since that time, several terms have emerged to 
describe delirium including: acute brain dysfunction, acute brain failure, acute brain 
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syndrome, acute cerebral insufficiency, acute confusion, acute confusional state, 
acute organic brain syndrome, acute organic psycho-syndrome, acute psycho-
organic syndrome, clouding of consciousness, clouded state, metabolic 
encephalopathy, and toxic–metabolic encephalopathy (6, 8, 9). Each of these 
concepts influenced the ultimate definition of delirium that was codified in the 
Diagnostic and Statistical Manual (DSM-III) of the American Psychiatric 
Association in 1974, and regularly updated to the current version in DSM-5 (8, 10, 
11). The full definition is shown in Table 1.1. 
 
Table 1.1. Delirium diagnosis: DSM-5 definition 
A. A disturbance in attention (i.e., reduced ability to direct, focus, sustain, and 
shift attention) and awareness (reduced orientation to the environment). 
B. The disturbance develops over a short period of time (usually hours to a few 
days), represents a change from baseline attention and awareness, and 
tends to fluctuate in severity during the course of a day. 
C. An additional disturbance in cognition (e.g., memory deficit, disorientation, 
language, visuospatial ability, or perception). 
D. The disturbances in Criteria A and C are not better explained by another 
preexisting, established, or evolving neurocognitive disorder and do not 
occur in the context of a severely reduced level of arousal, such as coma. 
E. There is evidence from the history, physical examination, or laboratory 
findings that the disturbance is a direct physiological consequence of 
another medical condition, substance intoxication or withdrawal (i.e., due to 
a drug of abuse or to a medication), or exposure to a toxin, or is due to 
multiple etiologies. 
Reprinted with permission from the Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition, (Copyright 2013). American Psychiatric Association. 
 
Delirium has far-reaching clinical and public health importance, yet it is an 
understudied neuropsychiatric disorder, especially when considering its overall 
impact on patients and healthcare systems (12). Delirium most commonly affects 
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individuals 65 and older, affecting over 2.6 million older Americans every year (12). 
It causes major burden and distress to patients, their caregivers and families, and 
healthcare professionals (13). Specifically, delirium is associated with increased 
length of hospital stay, increased rates of admission to long-term care institutions, 
and increased subsequent risk of developing dementia (12, 14). Mortality rates 
reach one quarter to one third of patients within two years of an episode of delirium 
(15). Medicare expenditures approach over $160 billion annually for excess 
healthcare expenditures attributable to delirium in the United States (16). In the 
year following an episode, the average delirious patient costs over $60,000 more 
to the healthcare system than those who did not develop delirium after adjustment 
for relevant confounders (17). Importantly, delirium is preventable in many cases 
(18).  
 
Despite its clinical importance, recognition of delirium remains a major problem. A 
recent study showed 61% of hospitalized patients confirmed to have delirium by a 
palliative care expert, had the delirium diagnosis missed by the primary referring 
team (19). At least part of the problem with recognition of delirium has been 
attributed to the lack of a unified instrument for its identification. Thus, the 
development of a widely accepted, unified identification instrument for delirium 
would greatly assist with recognition, and would help with prevention and 




Delirium has risen in importance for public health during the 2020 global pandemic 
of COVID-19. A recent study found over a quarter of older persons presenting to 
the emergency department with COVID-19 infection have delirium, which was the 
sixth most common presenting symptom overall (20). Another study found delirium 
was present in a third of hospitalized patients with COVID-19 (21). It is imperative 
to recognize that delirium is a common, atypical presentation of COVID-19 or other 
viral infections. The consistent and accurate identification of delirium is critical and 
depends on valid measurement instruments. Thus, delirium is clearly an 
important medical condition with far-reaching public health implications, 
and this project focused on applying advanced measurement methods to 
improve the identification of delirium. 
 
 
Overview of Measurement 
Measurement has played a vital role in human survival and the flourishing of 
civilization since prehistoric times. For example, at the origin of agrarian society, 
measurement was necessary to determine how many crops to grow to feed the 
community (22). Many of the original units of measurement were based on natural 
biological objects (i.e., fingers to represent length), however, such measurements 
tended to vary according to local circumstances and needs. Variability can be dealt 
with by taking the average of many biological objects or consistent use of more 
standard and unvarying physical objects. Another major problem in the early 
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application of measurement was a lack of consistency in units. Historically, it was 
found that towns within the same country would use units of measurement that 
were the same in name, but the actual quantity was unstandardized and differed 
between towns. Many countries used different units making trade and exchange 
across countries difficult. Thus, a unified system, known as the Système 
International d'Units or SI units, was ultimately developed (22). 
 
 
Classification of Measurement Approaches 
In 1946, the psychologist S.S. Stevens provided a fundamental advance in the 
field of measurement by classifying and defining different types of measurement 
approaches that could be applied widely (23). He defined measurement “as the 
assignment of numerals to objects or events according to rules. The fact that 
numerals can be assigned under different rules leads to different kinds of scales 
and different kinds of measurement” (23). These different kinds of scales included 
the following categories of measurement: nominal, ordinal, interval, and ratio (23) 
(Table 1.2). Nominal measures involve no inherent order in the categories. Ordinal 
measures do have an order in their categorization, but there is not a specific or 
consistent difference between each category. In interval measures, both the order 
and difference are specified and consistent between categories. Ratio measures 
are specific extensions of interval measures, where the value zero specifies the 
complete absence of what is being measured—an absolute zero. The end result 
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of these categorizations has been the development of mathematical derivations 
for each type of measurement, such that different categories or levels of the scale 
can be quantified numerically. 
 
In the present work, I used item response theory (IRT), which places a latent trait 
estimate on an interval scale (more background on IRT is provided below). This 
allows for the direct comparison of differences both between participants and 
scores simultaneously, which cannot occur with an ordinal scale. An example of a 
nominal measure is the Confusion Assessment Method (CAM) that uses an 
algorithm in the case identification of delirium versus no delirium (1). An example 
of an ordinal measure is any scale that uses a sum score, such as the Memorial 








Nominal No inherent order in the 
categories 
Hair color; Algorithm of case 
identification of delirium versus 
no delirium 
Ordinal Categories ordered, but 
no specific or consistent 
difference between each 
category 
Wong-Baker Faces Pain 
Rating Scale; Likert scale; 
Sum scores on delirium 
identification instruments 
Interval Both the order and 
difference are specified 
and consistent between 
categories 
Intelligence quotient (IQ); 
Temperature in Fahrenheit; 
IRT based estimates of the 
latent trait, propensity to 
delirium 
Ratio Specific kind of interval 
measures with absolute 
zero 
Age; Height; Weight; 
Temperature in Kelvin 
Definitions adapted from (22, 23). 
 
 
Clinical Measurement: Understanding Performance Characteristics 
This dissertation will focus on the importance of measurement to develop clinically 
useful measures to identify disease states. This section will elucidate topics and 
terms critical to evaluating the performance of a measurement instrument. A 
construct is an idea that contains key conceptual elements; in medicine, a 
construct is typically comprised of the signs and symptoms of a specific disease or 
disorder. In developing and evaluating measurement instruments, there are two 
key performance characteristics to understand: reliability and validity. Reliability of 
a measure refers to the consistency in findings on repeated measurements when 
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the patients have not changed (25, 26). Validity describes if a measurement 
instrument truly measures the construct it intends to measure (25, 26). Several 
different types of both reliability and validity exist, as detailed in Table 1.3. 
 
Table 1.3. Performance characteristics of measurement instruments 
Test 
characteristic 
Description (or definition) How assessed 
Reliability Consistency in findings on 
repeated measurements when 
the patients have not changed 
Minimal measurement 
error – intra-class 
correlation coefficient 
(ICC), standard error of 
measurement (SEM), 






different sets of items in a 
measurement instrument 





Comparing scores on an 
instrument over time with 
repeated testing, contributions 






Similarity of ratings of different 
observers making observations 
of the same patient at the same 
time 
Intra-class correlation 




Similarity of ratings the same 
observer at different time points 
Intra-class correlation 
coefficient (ICC), Cohen’s 
kappa 
Validity If a measurement instrument 
truly measures the construct it 
intends to measure 
See specific validity 
example types below 
Content validity Whether the subject matter and 
specific questions in an 
instrument correspond with the 
intended construct; both in 
terms of the relevance to the 
construct and measuring the 
full scope of the construct 
Subjective assessment of 
the extent to which the 
instrument contains 
relevant items that 




Face validity Part of content validity that 
shows that an instrument 
properly reflects the planned 
construct, generally determined 
by experts in the field 
Subjective assessment 
on the part of test users 
that the test is measuring 
the full construct 
Criterion validity How well the instrument 











risk ratios, odds ratios 
Convergent 
validity 
Scores that agree with 
measures on existing tests of 
the same construct 
Correlation coefficients, 
measures of agreement 
Construct validity Extent to which an instrument 
adequately measures the idea 
or concept of interest 
Totality of the evidence 
for reliability and validity  
Definitions adapted from (25, 26)  
 
Internal consistency reliability refers to the inter-relatedness between different sets 
of items in a measurement instrument (27). Inter-rater reliability refers to the 
similarity of ratings of different observers making observations of the same patient 
at the same time, while intra-rater reliability shows the similarity of ratings the same 
observer at different time points (27). When scores on an instrument are compared 
over time with repeated testing, that is known as test-retest reliability (27). To know 
a measure is reliable, it must have minimal measurement error, which can be 
calculated with statistics such as intra-class correlation coefficient (ICC), standard 
error of measurement (SEM), Cohen’s kappa, and McDonald’s Omega (27). 
 
Content validity pertains to the subject matter of the specific questions and items 
within the instrument, and whether they correspond with the intended construct to 
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be measured. Content validity covers both the relevance to the construct and 
measuring the full scope of the construct (for example administering items about 
all signs and symptoms relevant to a syndrome) (27). Face validity is a part of 
content validity that shows that an instrument properly reflects the planned 
measured disease (27), generally determined by experts in the field. In cases when 
the construct has a reference standard measurement, criterion validity refers to 
how well the new instrument compares to the reference standard in identifying the 
disease (27). Construct validity, originally coined for use in psychological tests by 
Cronbach and Meehl (28), is considered the fundamental aspect of validity and 
broadly means the extent to which an instrument adequately measures the idea or 
concept of interest (25, 29, 30). Construct validity can be informed by prediction of 
expected clinical outcomes (predictive validity) or scores that agree with measures 
on existing tests of same/similar constructs (convergent validity) (27). 
 
 
Clinical Measurement: Understanding Goals of Testing 
When constructing a test, it is important to know the intended usage of the test, 
and hence, design the test in such a way that will optimize that specific use. In 
other words, alternative uses of tests may lead the test designer to prioritize 
selecting different items during the construction of a new test for screening versus 
one for diagnosing or assessing severity. One should also put thought into if the 
desire is for inferences at the individual patient level or group-based. It is not 
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practical to develop a single test to serve all uses and all audiences 
simultaneously. In medical tests, these competing interests are often divided into 
discriminative and evaluative tests (31). In discriminative tests, one wants to 
distinguish differences between patients at a single point in time. In evaluative 
tests, one wants to measure the magnitude of construct, which can be useful in 
characterizing change over time. Therefore, the answers to questions on an 
evaluative test should change when health status changes, especially in relation 
to specific interventions or clinical events (32). More simply, discriminative tests 
define who is a case versus who is not a case, while evaluative tests show 
differences or change in health status (between groups, over time, or in response 
to treatment). It is possible to develop a test that can perform both these tasks; 
however, if the ultimate desire is only to address discriminative goals (e.g., 
diagnosis), then resources would be used inefficiently to also satisfy measurement 
properties that serve evaluative goals. For instance, participants would be asked 
too many questions, putting great burden on both the patients and the person 
administering the test. The test will not be adopted in practice if it is too long and 
burdensome to administer. A test needs to be as long as needed to do its job and 
no longer or shorter. In the present work, the interest was in delirium case 





Clinical Measurement: Identification of Disease 
In clinical medicine, measurement plays a critical role in the accurate screening 
and diagnosis of disease states. It is important to understand the similarities and 
differences of the performance characteristics needed for diagnosis and screening 
tasks, and their implications for medicine and public health. In a clinical medicine 
context, screening occurs before the onset of disease and typically refers to tests 
performed in an asymptomatic or preclinical patient to help prevent the later onset 
of disease. Screening can also refer to asking a few, quick broad questions or 
ordering a few generic tests to determine a patient’s level of risk for the disease. 
This can help the clinician to determine if more detailed questioning or testing is 
needed, such as identifying high-risk patients, who necessitate more close 
following and in which one might conduct early diagnostic testing. Diagnosis 
occurs after disease has occurred, and refers to the process of identification of the 
disease that explains the patient’s signs or symptoms. 
 
In a public health context, screening is often applied across a large group of people 
(i.e., at the population level) to assess which persons are at risk for a condition or 
already unknowingly have the condition, with a goal of helping to prevent the 
condition or its associated complications (33). For optimal screening, 
measurement instruments should select for maximal sensitivity, in order to avoid 
false negatives, or missing cases. Diagnosis refers to more detailed testing at an 
individual level, meant to confirm the existence of a condition in suspected patients 
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and to identify patients who need treatment. Diagnostic tests should select for 
maximal specificity, in order to avoid false positives and conducting more detailed 
or risky evaluations on cases without the condition.  
 
However, there are important distinctions to consider for delirium diagnosis in a 
research context. Due to feasibility constraints, large research studies cannot 
typically use reference standard diagnoses, such as by trained physicians. Instead, 
the use of epidemiologic criteria to approximate reference standard diagnoses is 
often implemented in the research setting. One method utilized are expert panels 
to help define approximate reference standard approaches for diagnostic use in 
research studies (34). Expert panels can assist in deciding on rules to classify 
people according to likely diagnosis, incorporating the results of the research 
assessments and taking clinical judgment into account. This method has been 
shown to be superior to individual diagnoses and the best method when true 
reference standards (such as laboratory tests or histopathology) are not available 
(35). However, studies that use expert panels do not always have standardized 
approaches of defining diagnoses or for reporting their results, which limits their 
replication in other studies. Thus, standards need to be developed for how to 
adequately report a study using an expert panel. 
 
In the context of delirium, there are additional challenges to screening and 
diagnosis. The formal diagnosis of delirium requires a detailed history, physical 
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examination, and laboratory testing, along with interviewing a knowledgeable 
informant who knows the patient well enough to report whether the current 
symptoms are a change from baseline. Currently, little is understood about the 
pathophysiology underlying delirium and no laboratory tests or imaging modalities 
exist as reference standards for diagnosis. The ability to fully assess the criteria 
laid out by the current reference standard, the DSM-5, requires an extensive time 
commitment and clinical expertise. Hence, this has led to the creation of many 
instruments to aid in the screening or diagnosis of delirium for a wide array of 
practitioners across clinical settings. 
 
Screening for delirium has inherent challenges. There are no rigorous guidelines 
about who to screen and at what time point. Due to a lack of a true reference 
standard delirium diagnosis, there is no current way to compare performance of 
different screening instruments (16). As with any other form of screening, delirium 
screening should ideally help identify patients who do not have delirium, but are at 
risk for delirium, in order to prevent complications; however, often the delirium 
screening instruments are utilized inappropriately as diagnostic instruments. A 
plethora of instruments for screening across different clinical settings and 
practitioners have developed over time. One example is the Confusion 
Assessment Method for the Intensive Care Unit (CAM-ICU), created to screen non-
verbal (intubated) patients in the intensive care unit (ICU), since the rates of 
delirium are quite high in that clinical setting (2, 3). Similar screening instruments 
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have been created for use in the emergency department and in long-term care 
facilities (36, 37). Another example of a screening instrument is the Delirium 
Observation Screening Scale (DOSS), created to provide a quick and easy 
approach for nurses to screen their patients for delirium, without requiring a 
physician (38). A unifying characteristic of delirium screening instruments is that 
they must be quick and easy to use. Some widely used instruments can be used 
for either screening (CAM short form) or diagnosis (CAM long form) (1). 
 
A major challenge in delirium is that the same instruments are used 
interchangeably for either screening and/or diagnosis, such that evaluation of 
studies can only focus on the combined “identification” of delirium. Thus, 
identification of delirium was selected as the focus of Chapter II, with a systematic 
review to comprehensively identify all delirium identification measures in active 
use. This first step to systematically inventory and evaluate all instruments in 
current use for identification of delirium was essential to select the best instruments 
for the subsequent analytic work. 
 
 
Item Response Theory (IRT) 
Item response theory (IRT) is an approach commonly utilized for advanced 
measurement development in healthcare, which evolved from work in educational 
testing in the 1950s-60s (39-41). Its application has greatly enhanced modern 
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psychometric research, and provides a robust approach to design and score 
measures (42). IRT defines a large grouping of statistical procedures created to 
associate discrete observations—such as responses to a questionnaire or 
symptom rating scale—to the underlying, but not directly observable latent trait 
(construct) presumed to cause the symptom. The key innovation of IRT is that it 
summarizes participants’ levels on underlying traits and test items separately along 
the same scale (43). The focus of IRT is to estimate the latent trait (27), which one 
can consider as the tendency of participants to endorse or exhibit a symptom of 
disease.  
 
While IRT is a powerful methodology for advancing measurement of constructs 
like delirium, it is important to understand some of its underlying assumptions. IRT 
assumes that a latent trait describes the probability of correctly responding to an 
item or endorsing a symptom, and that persons with a higher level on the latent 
trait have a higher probability of endorsing the symptom or answering the item 
correctly. A further assumption of conditional independence is fundamental to IRT, 
that is, the probability of a correct response is independent of other answers to 
items within the instrument, conditional on the level of the underlying latent trait 
(43). Another assumption involves the statistical and conceptual division of 
characteristics of symptoms (test items) and characteristics of participants. In IRT 
analyses, the latent trait is customarily assumed to have a normal distribution with 
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a mean of zero and standard deviation of one (44). Some key terms used in IRT 
analysis are presented and defined in Table 1.4.  
 
Table 1.4. Definitions of common IRT terms 
Item Response Theory (IRT) term Description (or definition) 
Latent trait Tendency of participants to endorse a 
symptom 
Conditional independence Probability of a correct response is 
independent of other answers to items 
within the instrument, and is conditional on 
the level of the underlying latent trait 
Difficulty parameter Level of the trait at which a participant 
picked randomly from the study population 
has a 50% probability of endorsing the 
symptom 
Discrimination parameter How well the symptom separates 
participants at low and high levels of the 
latent trait 
Harmonization Process of data transformation permitting 
different sources to be treated equivalently 
Item bank Collection of the individual instrument 
questions or ratings along with their 
parameter estimates derived from IRT 
analyses 
 
A two-parameter model is a common approach typically used and includes a 
difficulty parameter and a discrimination parameter. The difficulty parameter can 
be interpreted as the level of the trait at which a participant picked randomly from 
the study population has a 50% probability of endorsing the sign or symptom. The 
discrimination parameter describes how well the sign or symptom separates 




Applications of IRT: Harmonization and Item Banks 
Throughout this work, I use the term ‘harmonization’ to refer to statistical 
harmonization or methods to link and equate different instruments on the same 
metric. The definition of harmonization is “to transform data from different sources 
in a way that allows them to be treated as equivalent” (45). Harmonization is not 
considered a technical term, while linking or test score equating are other more 
technical terms seen in the literature (46, 47). The harmonization analysis 
performed in this work will occur through the approach described in the 
Harmonization of Cognitive Measures in Individual Participant Data and Aggregate 
Data Meta-Analysis, created by the Agency for Healthcare Research and Quality 
(47). In a formal harmonization study, there is a necessity to use statistical 
approaches that link measurement instruments across different studies. While 
many potential statistical methods would be suitable, there are clear advantages 
to linking using latent variable techniques inherent in IRT, which will be used in my 
analyses (47). IRT models specify a continuous latent trait that places all items of 
a construct on the same metric. This facilitates comparison, and ultimately direct 
statistical harmonization, between different instruments, even when there are 
overlapping, but disjointed items across instruments or administered to patients. 
 
Harmonization of the identified delirium identification instruments allows for the 
creation of an item bank. An item bank is a collection of the individual instrument 
questions or ratings along with their parameter estimates derived from IRT 
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analyses. Item banks have been widely used in the field of educational testing, 
such as the SAT and Medical College Admission Test (MCAT). These tests rely 
on item banks to create alternate forms of the test which are administered to 
varying participants on different days, and enable equivalent scoring across the 
alternate test forms. 
 
More recently, IRT has been utilized within health research. There are many 
National Institute of Health (NIH) initiatives to develop new and well-validated 
measurement instruments. One example is the Patient-Reported Outcomes 
Measurement Information System (PROMIS) (48). PROMIS investigators used 
IRT methods to help build quantitative measures to evaluate patient-reported 
outcomes, and to generate item banks for creation of new instruments.  
 
In this dissertation, I will utilize IRT methods to create a harmonized item bank, 
and to place the most commonly used and well-validated delirium identification 
instruments on the same metric, called the propensity to delirium. From the item 
bank, I will create new forms for different uses. For example, I can create short 
forms from the items in the item bank with high psychometric properties to 
accurately and efficiently screen for delirium, or long forms to confirm diagnosis or 





One major problem in the identification of delirium is that there is no single agreed 
upon identification instrument. In fact, a 2010 study found 24 different delirium 
identification measures in active use (49). Since the publication of that study, 
multiple additional delirium identification measures have been developed. The use 
of numerous different measures for delirium identification presents a potential 
hindrance to delirium research, as well as to clinical progress in the field. Of these 
measures, only a few meet criteria for robustness and proper validation. This 
poses a major problem, since different clinicians using different instruments may 
not agree on whether delirium is present or not, and thus, the diagnosis of delirium 
may not be accurate or consistent. It is difficult to directly compare studies that use 
different methods for detection, since they may disagree on the prevalence and 
features of delirium. Thus, results found in one study may not translate directly to 
another study. To overcome the problem of heterogeneity in delirium identification 
measures, I propose the use of modern psychometric measurement techniques to 
create a single harmonized item bank of delirium case identification. This will allow 
for better comparison between studies, as well as the ability to combine data from 
multiple studies. 
 
The overarching goal of this dissertation project is to apply advanced psychometric 
methods to improve the identification of delirium. This project will proceed with the 
following specific aims. 
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Specific Aim 1. Determine the 4 most commonly used and well-validated 
instruments for delirium identification through a systematic review of the 
medical literature, applying standardized methodologic quality ratings (Chapter 
II). 
Specific Aim 2. Harmonize the 4 most commonly used and well-validated 
delirium assessment instruments to generate an item bank, which is a 
collection of the individual instrument questions or ratings along with their 
parameter estimates derived from item response theory (IRT) analyses 
(Chapter III). 
Specific Aim 3. Explore applications of the harmonized item bank through 
several approaches. First, identifying different cut-points that will optimize: (a) 
balanced high accuracy (Youden’s J-Statistic), (b) screening (sensitivity), and 
(c) confirmation of diagnosis (specificity) in identification of delirium. Second, 
comparing performance characteristics of short forms (versus long forms) 






CHAPTER II – Detecting Delirium: A Systematic Review of Identification 
Instruments for Non-ICU Settings 
Chapter II is adapted almost verbatim from a manuscript I published in the Journal 




Objectives: Delirium manifests clinically in varying ways across settings. Over 40 
instruments currently exist for characterizing the varying manifestations of 
delirium. We evaluated all delirium identification instruments according to their 
psychometric properties and frequency of citation in published research. 
Design: We conducted the systematic review by searching CINAHL, Cochrane, 
EMBASE, PsycINFO, PubMed, and Web of Science from January 1, 1974-
January 31, 2020, with the key words “delirium” and “instruments”, along with 
their known synonyms. We selected only systematic reviews, meta-analyses, 
or narrative literature reviews including multiple delirium identification 
instruments. 
Measurements: Two reviewers assessed eligibility of articles and extracted data 
on all potential delirium identification instruments. Using the original publication 
on each instrument, the psychometric properties were examined using the 
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Consensus-based Standards for the Selection of Health Measurement 
Instruments (COSMIN) framework. 
Results: Of 2,542 articles identified, 75 met eligibility criteria, yielding 30 different 
delirium identification instruments. A count of citations was determined using 
Scopus for the original publication for each instrument. Each instrument 
underwent methodologic quality review of psychometric properties using 
COSMIN definitions. An expert panel categorized key domains for delirium 
identification based on criteria from the Diagnostic and Statistical Manual 
(DSM)-III through DSM-5. Four instruments were notable for having at least 2 
of 3 of the following: citation count ≥200, strong validation methodology in their 
original publication, and fulfillment of DSM-5 criteria. These were, 
alphabetically: Confusion Assessment Method (CAM), Delirium Observation 
Screening Scale (DOSS), Delirium Rating Scale-Revised-98 (DRS-R-98), and 
Memorial Delirium Assessment Scale (MDAS). 
Conclusion: Four commonly used and well-validated instruments can be 
recommended for clinical and research use. An important area for future 






Delirium is a major public health problem, impacting an estimated 2.6 million 
older Americans annually and accounting for over $164 billion in healthcare 
expenditures (16). Delirium disproportionately affects people over age 65 and is 
associated with prolonged hospitalization, cognitive decline, and heightened risks 
for dementia and death (12, 13). Clinically, many cases of delirium go 
unrecognized (50), representing missed opportunities for prevention of delirium 
(18). A study revealed that in 61% of hospitalized patients with confirmed 
delirium by a palliative care expert, the diagnosis was missed by the primary 
referring team (19). At least in part, the lack of a unified, accepted diagnostic 
approach adds to the challenges of recognition (51). 
 
The growing awareness of the seriousness of delirium, coupled with the fact that 
it remains a purely clinical diagnosis—without a laboratory test—has resulted in 
many tools for its detection. Currently, there are over 40 delirium instruments for 
different purposes (e.g., screening, diagnosis, and severity), targeting different 
clinical settings (e.g., intensive care unit (ICU), emergency department, medical 
wards), and intended for different users (e.g., psychiatrists, geriatricians, nurses). 
These instruments describe varying domains of delirium. This overabundance of 





Our overall goal was to examine instruments used for identification of delirium, 
defined as those used for screening or diagnosis. We aimed to conduct a 
comprehensive systematic review to identify the most commonly used and 
originally well-validated instruments for identification of delirium.  
 
Methods 
Our approach involved five steps. First, we performed a comprehensive search 
of the literature for reviews of delirium identification instruments from January 1, 
1974 through January 31, 2020. Second, we enumerated the citations of the 
original publication of each instrument. Third, we evaluated the psychometric 
characteristics of each instrument and rated the methodologic quality of the 
original publication of the instrument, employing the Consensus-based Standards 
for the Selection of Health Measurement Instruments (COSMIN) framework (25, 
27, 52). Fourth, we used an expert panel to identify the domains of delirium 
critical to identification based on Diagnostic and Statistical Manual of Mental 
Disorders (DSM) criteria. Finally, the expert panel used a combination of the 
count of citations, the COSMIN methodologic rating, and fulfillment of DSM 
criteria to determine the delirium identification instruments to recommend. 
 
Our approach to conducting and reporting of this systematic review followed the 
Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 
guidelines and Institute of Medicine (IOM) Standards for Systematic Reviews (53, 
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54). For the systematic review, our goal was to discover as many delirium 
identification instruments as possible. Since the goal of the study was to identify 
the most frequently cited instruments, we chose the accepted approach of a 
review of reviews as the most effective and efficient way to achieve this goal (55, 
56). Our search began in 1974, the year that the DSM-III first codified delirium 
(10), and was inclusive through January 31, 2020.  
 
Data Sources and Searches 
We identified articles through searches of 6 different databases: Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, 
Excerpta Medica Database (EMBASE), PsycINFO, PubMed, and Web of 
Science. The search terms included the keywords “delirium” and “instruments”, 
along with their known synonyms (Table 2.6). We limited articles to review 
articles (systematic review, meta-analysis, or narrative review) with delirium as 
the main outcome. We required articles to include a minimum of two instruments. 
For any systematic review of a single instrument, we ensured the instrument was 
included in another selected article before exclusion. Exclusion criteria included 
studies exclusively examining alcohol-related delirium (delirium tremens), studies 
exclusively in pediatric populations, and other article types (i.e., case reports, 
commentaries, letters, editorials, conference abstracts), or studies where no full-
text article was available. Because of the volume of citations to review by primary 
English language investigators, we restricted to English-language articles only. 
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Prior studies have indicated that this approach does not substantially bias 
systematic reviews (57). Figure 2.1 shows the flow diagram for selection of 
articles. The articles underwent first-pass screening based on the title and 
abstract, then second-pass screening was conducted using the full-text article. 
 





Title and Abstract Initial Screening 
Before screening, duplicates and non-English language articles were removed by 
Endnote X9 software and manual cross-check. The first-pass screening of title 
and abstract was completed by 2 independent reviewers (B.H., M.D.) to exclude 
articles that did not meet eligibility criteria. Each reviewer independently reviewed 
the abstracts and used the RAYYAN QCRI (58) software to record results, 
completely blinded to the other’s ratings. Articles without an abstract were 
included in the full-text review. If the article was rated as eligible by either of the 
two reviewers, the article was included for full-text review. Excluded articles were 
assigned a single reason for exclusion: studies restricted to pediatric populations; 
studies using only animal models; studies in which delirium was not the outcome; 
not a review; or did not evaluate at least two instruments (Figure 2.1). 
 
Full-Text Review 
After the first-pass review, two independent reviewers (B.H., P.T.) established 
final eligibility through full-text review. If the article was rated as eligible by either 
of the two reviewers, the article was included for data extraction. Each rater 
logged their results in a Google Form in a blinded fashion. Excluded articles were 
given a single reason for exclusion with the same options described. Since the 
goal of this step was to comprehensively identify all potential delirium 
identification instruments, we did not conduct an appraisal of the quality of these 
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reviews. We used the systematic reviews, combined with hand searches of 
references and consultations with experts to assure comprehensive identification. 
Once we had found all the instruments, then the next step was to appraise the 
quality of the original studies of those instruments. For eligible articles, 
information extracted included: citation, article type (systematic review, meta-
analysis, narrative review), databases and dates searched, search terms, and 
number of studies and instruments included in the review. Finally, to minimize 
biased selection based on requiring reporting in an electronic database, and as 
recommended by the IOM standards for systematic reviews (54), reviewers 
searched the reference lists of any included articles to identify other articles to 
include. We augmented our electronic search with hand reviews and with queries 
to our experts. 
 
Our goal was to identify all potential instruments used to identify delirium. A full 
list of the instruments discovered from the eligible articles was presented to our 
expert panel. We excluded those not specific to delirium (i.e., cognitive screens, 
sedation instruments, dementia instruments). With the expert panel, we identified 
several instruments specific to delirium not found in the systematic review to 
bolster our final list of eligible instruments. At this stage, the experts advised 
excluding instruments designed solely for use in the ICU since these patients are 
often non-verbal, resulting in the need for unique assessments that might not be 
comparable with other instruments or generalizable to other settings. In addition, 
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a systematic review of delirium identification instruments for the ICU had been 
recently published (59). Since this was a study of delirium identification 
instruments, we chose to additionally exclude instruments measuring only 
severity and subtypes (hypoactive or hyperactive). 
 
Citation Count 
We obtained the original publication for each of the eligible delirium identification 
instruments. The count of citations of the original publication was determined 
from Scopus for the date range January 1,1974-January 31, 2020. 
 
COSMIN-Guided Methodologic Rating 
Our goal for the second-stage review was to evaluate the psychometric 
characteristics of the instrument and the methodologic quality of the original 
publication for each selected delirium instrument. We chose the single earliest 
publication for each instrument. We made an exception for the Delirium Rating 
Scale (DRS) and used the later study since the instrument had been revised 
[Delirium Rating Scale-Revised-98 (DRS-R-98)]. We rated the Confusion 
Assessment Method (CAM) long form and short form separately. A single 
publication per instrument was used to minimize bias as older instruments might 
have multiple validation studies. Our quality rating was based on an approach we 
published previously (Table 2.7) (9). Our approach used the COSMIN standards 
of measurement properties (25, 27, 52). The COSMIN rating was utilized to 
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evaluate the psychometric properties of the instrument as reported in its original 
study. Each article was reviewed independently in a blinded fashion by at least 
two of three reviewers (B.H., K.E., J.Y.) and rated according to the COSMIN 
framework. The assessment items include ratings of published descriptions of 
effect indicators, internal consistency, content validity, inter-rater reliability, 
construct/convergent validity, and criterion validity (full definitions and scoring are 
in Table 2.7). Estimates and sample sizes for these different types of reliability 
and validity were recorded. The few small differences between the two 
independent COSMIN ratings of each article were adjudicated by a third rater 
(R.N.J.). 
 
The ratings on each of the COSMIN criteria were summed and reported as a 0 to 
6 score (Table 2.7), using an adaptation of the COSMIN scoring procedure 
published previously (9, 26). For reporting on each of these categories the 
instruments were given one point; failure to report on these categories resulted in 
no points. If a category was reported, but used sample sizes less than 50, only a 
half point was assigned. 
 
Expert Panel Review of Instruments 
We assembled an interdisciplinary expert panel to determine the key domains for 
identification of delirium and ascertained their alignment with DSM criteria. 
Experts from geriatric medicine (S.K.I., T.T.H., one anonymous), geriatric 
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psychiatry (E.D.M.), cognitive neurology (T.G.F.), gerontological nursing (P.T.), 
and social work (E.M.S.) were included in the panel. Face-to-face meetings were 
done twice in consensus sessions following a modified Delphi approach (35, 60) 
to adjudicate the criteria, with independent, blinded ranking assignments 
between meetings. We reviewed criteria enumerated in DSM-III, DSM-III-R, 
DSM-IV, DSM-IV-TR, and DSM-5 (10, 11, 61-63). Each individual criterion was 
first assigned to domain(s) identified previously (9, 64). Then, the expert panel 
rated whether each domain was essential for delirium identification; consensus 
was considered achieved with agreement by 6/7 (86%). The expert panel 
determined whether each of the 30 delirium identification instruments fulfilled 
DSM-5 criteria. 
 
Subsequently, the expert panel determined the criteria for selecting the 
instruments to recommend. After consensus, the following criteria were selected: 
citation count ≥200, COSMIN score >4, and meeting full DSM-5 criteria. To be 
recommended, an instrument should meet at least 2 of these 3 criteria. 
 
Results 
Results of the systematic review are shown in Figure 2.1. The literature review 
yielded 2,542 articles, which were narrowed based on our exclusion criteria to 
160 articles for full-text review. From full-text review, 75 articles (47%) met our 
inclusion criteria (Table 2.8). We identified 89 total instruments. The expert panel 
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determined 49 were specific to delirium; we excluded 19 for the following 
reasons: measuring severity only (n=8); intended for ICU patients (n=5); 
measuring only delirium subtypes (hypoactive or hyperactive) (n=2); measuring 
only risk for developing delirium (n=1); including only attention tests (n=1); 
published before 1974 (n=1); and case report only (n=1) (Table 2.9). Thus, our 
study included 30 delirium-specific identification instruments developed for use in 
non-ICU settings (Table 2.10). Of these 30 instruments, allowing for multiple 
categories, usage was 87% for screening, 27% for diagnosis, and 10% for 
severity. The most common study populations examined included: medical 
and/or surgical wards (47%), geriatric wards (20%), emergency department 
(10%), and long-term care facilities (10%). The reference standard used for each 
study included: DSM (40%), CAM (20%), expert clinical judgment only (13%), 
and not described or not used (27%). 
 
Table 2.1 shows characteristics of the full-text articles reviewed. There were 18 
articles that mentioned at least 10 instruments. No articles were published before 
1990, however, since that time article count has risen exponentially. The 75 




Table 2.1. Characteristics of articles reviewed 
Characteristic N % 
Number of instruments described 
(n, %) 
75 100 
 2 9 12 
 3 4 5 
 4 6 8 
 5 13 18 
 6 8 11 
 7 7 9 
 8 7 9 
 9 3 4 
 10-14 8 11 
 15-19 4 5 
 20 6 8 
Year published (n, %)   
  1974‐1989 0 0 
  1990‐2000 5 7 
  2001‐2010 17 23 
  2011‐2014 25 33 
  2015‐2019 28 37 
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Article Type (n, %)   
 Meta-analysis 5 7 
 Systematic review 23 30 
 Narrative review 47 63 
 
 
Table 2.2 shows the selection criteria for all the delirium identification 
instruments. Four instruments stand out for satisfying most of the COSMIN 
framework criteria, assessing many of the DSM-5 criteria, and widespread use as 
evidenced by their high citation count. These were the Confusion Assessment 
Method (CAM) [2,685 citations, COSMIN criteria count = 4.5, full DSM-5 criteria], 
Delirium Rating Scale-Revised-98 (DRS-R-98) [499 citations, COSMIN criteria 
count = 4.5, full DSM-5 criteria], Memorial Delirium Assessment Scale (MDAS) 
[492 citations, COSMIN criteria count = 5, partial DSM-5 criteria], and the 
Delirium Observation Screening Scale (DOSS) [212 citations, COSMIN criteria 








Table 2.2. Selection criteria for delirium identification instruments based on the original citation  


















Confusion Assessment Method (CAM) - Long Form and Short 
Form 
2909 4.5 Yes 
Delirium Rating Scale-Revised-98 (DRS-R-98) 552 4.5 Yes 
Memorial Delirium Assessment Scale (MDAS) 532 5 No 
Delirium Observation Screening Scale (DOSS) 238 6 No 
Chart Delirium Identification (CHART-DEL) 216 3.5 No 
Neelon and Champagne confusion scale (NEECHAM) 207 5 No 
Delirium Symptom Interview (DSI) 204 4 No 
Confusion Assessment Method Emergency Department (CAM-
ED) 
176 2.5 No 
4 "A"s test (4AT) 168 4 No 
Delirium Triage Screen (DTS) 117 4 No 
Brief Confusion Assessment Method (bCAM) 117 4 No 
3-Minute Diagnostic Assessment (3D-CAM) 98 4 Yes 
Saskatoon Delirium Checklist (SDC) 97 2 No 
Single Question in Delirium (SQiD) 64 2 No 
Nursing Home-Confusion Assessment Method (NH-CAM) 58 2 Yes 







Clinical Assessment of Confusion-A (CAC-A) 40 3.5 No 
Recoverable Cognitive Dysfunction Scale (RCDS) 34 2 No 
modified Confusion Assessment Method for the Emergency 
Department (mCAM-ED) 
28 3 No 
Delirium Diagnostic Tool-provisional (DDT-Pro) 27 3.5 No 
Confusion Rating Scale (CRS) 26 4 No 
Bedside Confusion Scale (BCS) 25 2.5 No 
Nursing Delirium Screening Scale (Nu-DESC) 24 2.5 No 
Recognizing Acute Delirium as Part of Your Routine (RADAR) 24 4 No 
Visual Analog Scale for Acute Confusion (VAS-AC) 22 3 No 
Inter Resident Assessment Instrument Acute Care (InterRAI 
AC) 
13 4 No 
Simple Query for Easy Evaluation of Consciousness (SQeeC) 10 4 No 
Informant Assessment of Geriatric Delirium scale (I-AGeD) 9 4.5 No 
Clinical Assessment of Confusion-B (CAC-B) NA 3.5 No 
Organic Brain Syndrome (OBS) NA NR NR 
*Descending order by count of citations.  
Abbreviations: COSMIN, Consensus-based Standards for the Selection of Health Measurement Instruments; DSM, Diagnostic and 





Figure 2.2 shows the domain coverage of the CAM, DOSS, DRS-R-98, and 
MDAS. Domains covered by each instrument were classified as fulfilling DSM-5 
criteria, other DSM diagnostic criteria, or other associated features. They are 
listed in descending order by number of total domains covered, with the DRS-R-
98 assessing 13 domains, the CAM long form assessing 11 domains, the MDAS 
assessing 10 domains, and the DOSS assessing 9 domains. The CAM short 
form overlaps with the CAM long form and was excluded from this analysis. For 
the DSM-5 criteria, all instruments included core criteria of inattention, 
disorientation, and cognitive impairment; however, two instruments (MDAS and 
DOSS) did not include acute onset and fluctuating course. In other DSM criteria, 
all 4 overlapped with the same domains on 4/6 criteria (disorganized thinking, 
psychomotor agitation, psychomotor retardation, and hallucinations), and all but 
the DRS-R-98 included altered level of consciousness. Only the DRS-R-98 
included organic etiology. 
 






Table 2.3 shows a comparison of the CAM, DOSS, DRS-R-98 and MDAS. These 
instruments had the highest citation count and COSMIN score. We also show the 
number of DSM-5 criteria and delirium identification domains met by each of the 
top 4 instruments. Table 2.3 provides additional information about these 
instruments including time for completion, qualifications of the raters, and 
evidence of construct and criterion validity. Notably, each of the instruments used 
a reference standard delirium diagnosis by a physician based on DSM criteria. 
Full details of the review of COSMIN criteria and other details for each instrument 
















Time to Complete 
Qualification






















(N = 56) 
10-15 minutes 




Trained lay or 
clinical raters 
r=.64 with MMSE 













(N = 92) 



























r=.41 with CTD DSM-IV criteria 
by referring 
service physician 
















r=.91 with MMSE 
r=.89 with CGR 















Abbreviations: CGR, Clinician’s Global Rating; CTD, Cognitive Test for Delirium; DRS, Delirium Rating Scale; DSM, Diagnostic and 
Statistical Manual; COSMIN, Consensus-based Standards for the Selection of Health Measurement Instruments; MMSE, Mini-Mental 
State Examination; VAS-C, Visual Analog Scale for Confusion. 
aConstruct validity represents a test of correlations with other instruments of the same construct, in this case delirium identification. For r, 
>0.7 indicates a strong relationship, >0.5 indicates a moderate relationship, and >0.3 indicates a weak relationship. 













Points, up to 1 for each category (content, effect indicators, internal 






Screening Scale (DOSS) 6   
Memorial Delirium 
Assessment Scale (MDAS) 5 
-1/2 for fair sample size or smaller (<50) for internal consistency reliability 
-1/2 for fair sample size or smaller (<50) for inter-rater reliability 
Neelon and Champagne 
confusion scale (NEECHAM) 5 -1 not all effect indicators 
Confusion Assessment 
Method (CAM) – Long Form 
and Short Form 
4.5 
-1 No internal consistency reliability 
-1/2 for fair sample size or smaller (<50) for inter-rater reliability 
Delirium Rating Scale 
Revised-98 (DRS-R-98) 4.5 
-1/2 for fair sample size or smaller for internal consistency reliability 
-1/2 for fair sample size or smaller (<50) for inter-rater reliability 
-1/2 for fair sample size or smaller (<50) for criterion validity 
Informant Assessment of 
Geriatric Delirium scale (I-
AGeD) 
4.5 
-1 No interrater reliability 
-1/2 for fair sample size or smaller (<50) for construct validity 
Confusion Rating Scale (CRS) 
4 
-1 No internal consistency reliability 
-1 No external validation 
3-Minute Diagnostic 
Assessment (3D-CAM) 4 
-1 No internal consistency 
-1 No construct validity 
4 "A's" Test (4AT) 
4 
-1 No interrater reliability 
-1 No construct validity 
Brief Confusion Assessment 
Method (b-CAM) 4 
-1 No internal consistency 







Delirium Triage Screen (DTS) 
4 
-1 No internal consistency 
-1 No construct validity 
Delirium Symptom Interview 
(DSI) 4 
-1 not all effect indicators 
-1 No construct validity 
Inter Resident Assessment 
Instrument Acute Care 
(InterRAI AC) 
4 
-1 No internal consistency 
-1 No construct validity 
Recognizing Acute Delirium 
as Part of Your Routine 
(RADAR) 
4 
-1 No content validity 
-1 No internal consistency 
Simple Query for Easy 
Evaluation of Consciousness 
(SQeeC) 
4 
-1 No internal consistency 
-1 No interrater reliability 
Clinical Assessment of 
Confusion-A (CAC-A) 3.5 
-1 No internal consistency 
-1/2 for fair sample size or smaller (<50) for inter-rater reliability 
-1 No criterion validity 
Clinical Assessment of 
Confusion-B (CAC-B) 3.5 
-1/2 small sample size (<50) for inter-rater reliability 
-1 No construct validity 
-1 No criterion validity 
Chart Delirium Identification 
(CHART-DEL) 3.5 
-1 No internal consistency 
-1/2 interrater reliability sample size and methods not reported 




-1 No internal consistency 
-1/2 inter-rater reliability sample size not reported 
-1/2 for fair sample size or smaller (<50) for construct validity 





-1 No internal consistency 
-1/2 inter-rater reliability sample size not reported 








assessment method for the 
ED (mCAM-ED) 
3 
-1 No internal consistency 
-1 No interrater reliability 
-1 No construct validity 
Visual Analog Scale for Acute 
Confusion (VAS-AC) 
3 
-1 uncertain effect indicators 
-1 No internal consistency 
-1/2 for fair sample size or smaller (<50) for interrater reliability 
-1/2 No correlations given for construct validity 
Nursing Delirium Screening 
Scale (Nu-DESC) 
2.5 
-1 No internal consistency 
-1 No inter-rater reliability 
-1/2 unclear sample size reporting (construct validity) 
-1 No external validation 
Bedside Confusion Scale 
(BCS) 
2.5 
-1 No internal consistency 
-1 No inter-rater reliability 
-1/2 for fair sample size or smaller (<50) 
-1 No construct validity 
Confusion Assessment 
Method-Emergency 
Department (CAM-ED) 2.5 
-1 No internal consistency 
-1 No interrater reliability 
-1 No construct validity 
-1/2 for fair sample size or smaller (<50) for criterion validity 
Recoverable Cognitive 
Dysfunction Scale (RCDS) 
2 
-1 Content validity not discussed 
-1 No internal consistency 
-1 No interrater reliability 
-1 No external validity 
Nursing Home Confusion 
Assessment Method (NH-
CAM) 2 
-1 uncertain effect indicators 
-1 No internal consistency 
-1 No construct validity 







Saskatoon Delirium Checklist 
(SDC) 
2 
-1 No internal consistency 
-1 No inter-rater reliability 
-1 No construct validity 
-1 No criterion validity 
Single Question in Delirium 
(SQiD) 
2 
-1 uncertain content validity 
-1 No internal consistency reported 
-1 No interrater reliability 
-1/2 for fair sample size or smaller (<50) for construct validity 
-1/2 for fair sample size or smaller (<50) for criterion validity 
Organic Brain Scale (OBS) NR   































2 minutes to 
administer and 
rate 




~1 minute Trained lay 
raters 
NR DSM-IV criteria 
by psychiatrist 




Not reported Trained nurses NR Interviewer rating 
using the CAM 


















(long form), 3-5 
minutes (short 
form) 
Trained lay or 
clinical raters 
r=.64 with MMSE 








Long form = 9 






including MMSE, 5 
minutes to 
Trained nurses 
working in the 























Not reported Not reported r = 0.889 DRS-
R-98 
DSM-IV-TR 



































r=.41 with CTD DSM-IV criteria 
by referring 
service physician 
Total = 16 






10-15 minutes for 
interview 
Clinicians or lay 
raters 
NR Clinical judgment 
of psychiatrist 
and neurologist 
32 4 204 
Delirium Triage 
Screen (DTS) 
~20 seconds Trained lay 
raters 
NR DSM-IV criteria 
by psychiatrist 






5-10 minutes Trained lay or 
clinical raters 
NR CAM rated by 
trained research 
assistants 











Not reported Trained 
caregivers 













Not reported Trained nurses NR DSM-IV criteria 
by geriatrician 















r=.91 with MMSE 
r=.89 with CGR 














One minute to rate 
attention and 3 to 


















Nurses r = .87 MMSE DSM-III-R 
criteria by trained 
research nurse 




~1 minute Nurses r = .71 DSM-IV 
r = .67 MDAS 




Not reported Nursing home 
staff 











NA NA NR NR NA NR NA 
Recognizing 
Acute Delirium 
as Part of Your 
Routine 
(RADAR) 
<1 minute to 
score, average of 
7 seconds 
Nursing or other 
clinical staff, 
can be rated by 
trained lay rater 














Not reported Not reported Kappa = 0.93 








15 minutes to 
administer 
Not reported NR NR 9 2 97 





30 seconds to 1 
minute 
Not reported Sensitivity of 
83%, specificity 
















1 2 64 
Visual Analog 
Scale for Acute 
Confusion (VAS-
AC) 






















3 minutes to rate Trained lay 
raters or 
clinicians 












4 "A"s test (4AT) <2 minutes 
including brief 
cognitive testing 
embedded in the 
interview 




4 4 168 
Abbreviations: CAMDEX, Cambridge Mental Disorders of the Elderly Examination; CGR, Clinician’s Global Rating; CTD, 
Cognitive Test for Delirium; DRS, Delirium Rating Scale; DSM, Diagnostic and Statistical Manual; COSMIN, Consensus-
based Standards for the Selection of Health Measurement Instruments; MMSE, Mini-Mental State Examination; NA, not 
attainable; NR, no rating; SPMSQ, the short portable mental status questionnaire; VAS-C, Visual Analog Scale for 
Confusion. 
aConstruct validity represents a test of correlations with other instruments of the same construct, in this case delirium 
identification. For r, >0.7 indicates a strong relationship, >0.5 indicates a moderate relationship, and >0.3 indicates a weak 
relationship. 





The ability to accurately identify delirium is important to provide optimal clinical 
care. Moreover, to advance the field, it is critical to have reliable approaches for 
delirium identification. We identified 30 delirium identification instruments used in 
non-ICU settings. We evaluated several aspects of each instrument including 
citation count, satisfaction of COSMIN criteria for the evaluation of health 
measurement instruments, and expert panel guidance regarding the coverage of 
DSM-5 criteria for delirium. Based on our systematic review combined with an 
expert panel process, we recommend (in alphabetical order) the CAM, DOSS, 
DRS-R-98, and MDAS as frequently used and well-validated instruments to 
identify delirium that are at least partially consistent with the current diagnostic 
framework (DSM-5) for delirium. 
 
Each of these instruments identifies delirium somewhat differently, assessing 
different domains. Each was designed for use by different users in varying 
clinical settings. Thus, the choice in selecting an instrument to identify delirium 
should be guided by these factors along with logistical considerations for the 
intended clinical or research application. While different instruments may be 
preferred for clinical versus research uses, both settings seek approaches to 
maximize reliability, validity, and minimize costs and burden of assessment. 
However, in the clinical setting, users often prioritize expediency, which may be 





For the selected instruments, to assist nurses in rapid delirium identification 
during each shift, the DOSS provides a brief (<5 minute) rating with minimal 
training. Although the ratings gather important information assessing clinical 
progress, an experienced clinician is required to confirm and establish 
diagnoses. Use of the DRS-R-98 may be preferred by skilled psychiatrically-
trained clinicians since it provides detailed ratings and has been used in 
phenomenological delirium studies. However, the administration of the DRS-R-98 
is time consuming (20-30 minutes) and labor intensive compared. The MDAS is 
scored with or without additional tests such as the Mini-Mental State Examination 
(24). However, all three of these instruments have no built-in diagnostic 
algorithm, and use cut-points to identify delirium. Thus, a delirium diagnosis can 
be achieved with multiple different domains. 
 
The CAM can be rated by trained lay interviewers, nurses, or physicians. Scored 
according to a diagnostic algorithm, the CAM aligns with the DSM-5 diagnostic 
criteria. There are two forms, a short-form which allows rapid assessment (<5 
minute) and a long-form (10-15 minutes) to help establish diagnoses in clinical 
and research applications. The availability of two different forms may offer 
advantages for large-scale clinical applications or studies. The CAM has been 




short-form is widely used as a reliable screening instrument (1, 65, 66), it does 
not cover as many domains as the other selected instruments. 
 
Our work extends the findings of two previous reviews. Adamis and colleagues 
used extensive search strategies to define the features of 24 different delirium 
instruments, including their psychometric properties (49), which were rated on a 
scale from +++ to -. This review did not utilize a uniform approach to characterize 
psychometric properties reported across studies. They recommended the CAM, 
DRS, MDAS, and Neelon and Champagne Confusion Scale (NEECHAM) due to 
their robustness and ease of use. Our work extends this article by updating the 
search and instruments included over the past decade, and providing a more 
systematic approach to scoring psychometric and methodologic properties. 
Subsequently, van Velthuijsen and colleagues used an extensive search strategy 
to find 28 different delirium instruments (67). Any study that described 
psychometric properties of delirium identification instruments was included. The 
studies were restricted to those that included reference standard delirium 
diagnoses made by a physician using the DSM, editions III, IV or 5 or the 
International Classification of Diseases (ICD-10). Their quality assessment was 
guided by QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) (68), 
which assesses 4 domains including patient selection, index test, reference 
standard, and flow and timing. The psychometric properties included in their 




consistency reliability. They recommended the CAM and Nursing Delirium 
Screening Scale (Nu-DESC), and the DOSS, DRS-R-98, and CAM-Intensive 
Care Unit (CAM-ICU) were mentioned. Our study extends this previous work by 
considering citation counts, aligning the instruments with DSM criteria and 
addressing other aspects of validity. 
 
There are several strengths to the present study. We used rigorous approaches, 
including PRISMA and IOM guidelines, to guide our comprehensive systematic 
review. We included a count of citations of the original publication of each 
instrument, along with methodologic quality ratings based on the COSMIN 
approach. We used an expert panel process to determine the domains for 
delirium identification, and applied them to each instrument item. A major 
strength includes our review of every DSM delirium criterion since the original 
codification of delirium in DSM-III. By reviewing each version, we were able to 
identify an inclusive consensus listing of domains pertinent to delirium 
identification. This allowed for each version of DSM to be included, many of 
which served as the reference standards in the original publication. We further 
aligned each of our recommended instruments with the diagnostic criteria of the 
current DSM-5. We followed IOM guidelines to ensure instruments were not 
missed by including hand searches and consulting with experts about other 





Several limitations deserve comment. First, there is a potential bias as one of the 
authors (S.K.I.) is a creator of four delirium identification instruments found in our 
review [CAM, Chart Delirium Identification (CHART-DEL), Family-Confusion 
Assessment Method (FAM-CAM), and 3-Minute Diagnostic Assessment (3D-
CAM)]. Additionally, coauthors E.D.M and R.N.J. are creators of the 3D-CAM. 
We minimized bias by not including any of these coauthors in the direct COSMIN 
review of any instruments. Second, restricting the COSMIN review to the original 
publication of each instrument poses another potential limitation. It is possible 
that had we probed the literature for validation studies for each instrument, we 
could have amassed more evidence for each instrument. Third, we understand 
that using citation count could potentially bias towards older instruments, 
however, this was only one of three criteria that the expert panel selected to rank 
the quality of the instruments, the other two—COSMIN score and DSM-5 
criteria—would not be biased by the age of the instrument. Fourth, we only 
considered the presence or absence of a validity or reliability assessment in an 
original instrument publication as a marker of the rigor of the original 
presentation. Our ranking may have been more precise if we had incorporated 
actual values of statistics used in the evaluation. However, not all studies 
reported all or the same statistics, used samples representative of different 
populations, and used different reference standards. These differences led us to 
take a very coarse approach to ranking the rigor of the original publication. Fifth, 




for ICU patients. We acknowledge that this systematic review is not generalizable 
to the ICU setting. Finally, the ability to distinguish delirium in persons with 
underlying dementia is an area of paramount importance for future investigation. 
Future work will be needed to rate and rank delirium identification instruments for 
their ability to differentiate delirium and dementia or to identify delirium 
superimposed on dementia. 
 
This study provides a broad overview of delirium identification instruments. We 
found numerous instruments used in different clinical settings by different raters. 
We were unable to recommend a single instrument for universal use, however, 
we found 4 instruments that are widely used and were well-validated in their 
original publications with a wide-range of clinical and research applications. The 
study helped to refine the construct of delirium through alignment of the delirium 
assessment items, DSM diagnostic criteria, and other previously identified 
delirium domains. While many studies have been published using different 
delirium identification instruments, comparing these studies is difficult due to the 
measurement heterogeneity. An important area for future investigation will be to 
harmonize these measures, which may help to compare results across studies, 
and to combine results from existing studies to form large datasets exploring 
pathophysiology and treatment. We hope this work will help to unify the field 





Table 2.6. Search strategies for databases 
 
PubMed 
Platform: PubMed, 1946-Present 
Year Limits: 1974-Present 
Other Limits: Language filter: English 
 
#1 "Delirium"[MeSH] OR "Delirium"[tiab] OR "Acute confusion"[tiab] OR 
"Acute organic brain syndrome"[tiab] OR "Acute confusional 
state"[tiab] OR "Acute brain syndrome"[tiab] OR "Acute brain 
failure"[tiab] OR “Acute brain dysfunction”[tiab] OR "Acute organic 
psychosyndrome"[tiab] OR “Acute organic psycho-syndrome”[tiab] 
OR "Acute psycho-organic syndrome"[tiab] OR “Acute 
psychoorganic syndrome”[tiab] OR "Metabolic encephalopathy"[tiab] 
OR “Clouded state”[tiab] OR “Clouding of consciousness”[tiab] 
#2 "Psychiatric Status Rating Scales"[MeSH] OR "Neuropsychological 
Tests"[MeSH] OR "Psychometrics"[MeSH] OR "Mass 
Screening"[MeSH] OR "Geriatric Assessment"[MeSH] OR 
"Psychological Tests"[MeSH] OR "Surveys and 
Questionnaires"[MeSH] OR "Interview, Psychological"[MeSH] OR 
"Mental Status Schedule"[MeSH] OR "Qualitative Research"[MeSH] 
OR "Checklist"[MeSH] OR "Scale"[tiab] OR "Scales"[tiab] OR 
"Instrument"[tiab] OR "Instruments"[tiab] OR "Measure"[tiab] OR 
"Measures"[tiab] OR "Questionnaire"[tiab] OR "Questionnaires"[tiab] 
OR "Interview"[tiab] OR "Interviews"[tiab] OR "Evaluation"[tiab] OR 
"Evaluations"[tiab] OR "Examination"[tiab] OR "Examinations"[tiab] 
OR "Exam"[tiab] OR "Exams"[tiab] OR "Test"[tiab] OR "Tests"[tiab] 
OR "Screening"[tiab] OR "Screenings"[tiab] OR "Assessment"[tiab] 
OR "Assessments"[tiab] OR "Index"[tiab] OR "Indices"[tiab] OR 
"Indexes"[tiab] OR "Qualitative Research"[tiab] OR "Qualitative 
Study"[tiab] OR "Qualitative Studies"[tiab] OR "Checklist"[tiab] OR 
"Checklists"[tiab] 
#3 "Adult"[MeSH] OR "Young Adult"[MeSH] OR "Aged"[MeSH] OR 
"Aged, 80 and over"[MeSH] OR "Frail Elderly"[MeSH] OR 
"Adult"[tiab] OR "Adults"[tiab] OR "Young Adult"[tiab] OR "Young 
Adults"[tiab] OR "Middle age"[tiab] OR "Middle aged"[tiab] OR 
"Elderly"[tiab] OR "Elder"[tiab] OR "Oldest old"[tiab] OR 
"Nonagenarian"[tiab] OR "Nonagenarians"[tiab] OR 
"Octogenarian"[tiab] OR "Octogenarians"[tiab] OR 
"Centenarian"[tiab] OR "Centenarians"[tiab] OR "Frail"[tiab] 
#4 "Alcohol withdrawal delirium"[MeSH] OR "Alcohol withdrawal 





#5 "review"[Publication Type] OR "review literature as topic"[MeSH 
Terms] OR "systematic review"[All Fields] OR "meta-
analysis"[Publication Type] OR "meta-analysis as topic"[MeSH 
Terms] OR "meta-analysis"[All Fields] 
#6 #1 AND #3 
#7 #6 NOT #4 






Platform: Elsevier, 1947-Present; Ovid, 1988-present 
Year Limits: [01/01/1974]/sd; present 
Other Limits: English language 
 
1 delirium/ or intensive care psychosis/ or postoperative delirium/ 
2 (delirium or acute confusion or acute organic brain syndrome or 
acute confusional state or acute brain syndrome or acute brain 
failure or acute organic psychosyndrome or acute psycho-organic 
syndrome or metabolic encephalopathy or clouded state or clouding 
of consciousness).tw. 
3 or/1-2 
4 psychological rating scale/ or psychometry/ or mass screening/ or 
geriatric assessment/ or exp psychologic test/ or exp questionnaire/ 
or qualitative research/ or rating scale/ or clinical assessment tool/ 
or clinical assessment/ or exp interview/ or clinical evaluation/ or 
screening test/ 
5 (mental status schedule or scale or scales or instrument or 
instruments or measure or measures or questionnaire or 
questionnaires or interview or interviews or evaluation or 
evaluations or exam or exams or examination or examinations or 
test or tests or screening or screenings or assessment or 
assessments or index or indices or indexes or qualitative research 
or qualitative study or qualitative studies or checklist or 
checklists).tw. 
6 or/4-5 
7 adult/ or middle aged/ or young adult/ or aged/ or frail elderly/ or 
very elderly/ 
8 (adult or adults or young adult or young adults or middle age or 
middle aged or elderly or elder or oldest old or nonagenarian or 
nonagenarians or octogenarian or octogenarians or centenarian or 
centenarians or frail).tw. 
9 or/7-8 
10 delirium tremens/ 












Platform: EBSCO, 1981-Present 
Other Limits: English language 
S1  (MH "Delirium") OR (TI Delirium OR AB Delirium) OR (TI "Acute 
organic brain syndrome" OR AB "Acute organic brain syndrome") OR 
(TI "Acute confusion" OR AB "Acute confusion") OR (TI "Acute 
confusional state" OR AB "Acute confusional state") OR (TI "Acute 
brain syndrome" OR AB "Acute brain syndrome") OR (TI "Acute 
brain failure" OR AB "Acute brain failure") OR (TI “Acute brain 
dysfunction” OR AB “Acute brain dysfunction”) OR (TI "Acute organic 
psychosyndrome" OR AB "Acute organic psychosyndrome") OR (TI 
“Acute organic psycho-syndrome” OR AB “Acute organic psycho-
syndrome”) OR (TI "Acute psycho-organic syndrome" OR AB "Acute 
psycho-organic syndrome") OR (TI “Acute psychoorganic syndrome” 
OR AB “Acute psychoorganic syndrome”) OR (TI "Metabolic 
encephalopathy" OR AB "Metabolic encephalopathy”) OR (TI 
“Clouded state” OR AB “Clouded state”) OR (TI “Clouding of 
consciousness” OR AB “Clouding of consciousness”) 
S2 (MH "Checklists") OR (MH "Behavior Rating Scales") OR (MH 
"Interview Guides+") OR (MH "Psychological Tests+") OR (MH 
"Questionnaires+") OR (MH "Scales") OR (MH "Instrument 
Construction+") OR (MH "Patient Assessment") OR (MH "Health 
Screening") OR (MH "Neuropsychological Tests") OR (MH 
"Psychometrics") OR (MH "Interviews+") OR (MH "Clinical 
Assessment Tools") OR (MH "Short Portable Mental Status 
Questionnaire") OR MH “Qualitative studies” OR MH “Qualitative 
research” OR (TI scale OR AB scale) OR (TI scales OR AB scales) 
OR (TI instrument OR AB instrument) OR (TI instruments OR AB 
instruments) OR (TI measure OR AB measure) OR (TI measures OR 
AB measures) OR (TI questionnaire OR AB questionnaire) OR (TI 
questionnaires OR AB questionnaires) OR (TI interview OR AB 
interview) OR (TI interviews OR AB interviews) OR (TI evaluation 
OR AB evaluation) OR (TI evaluations OR AB evaluations) OR (TI 
examination OR AB examination) OR (TI examinations OR AB 
examinations) OR (TI exam OR AB exam) OR (TI exams OR AB 
exams) OR (TI test OR AB test) OR (TI tests OR AB tests) OR (TI 
screening OR AB screening) OR (TI screenings OR AB screenings) 
OR (TI assessment OR AB assessment) OR (TI assessments OR 
AB assessments) OR (TI index OR AB index) OR (TI indices OR AB 
indices) OR (TI indexes OR AB indexes) OR (TI checklist OR AB 
checklist) OR (TI checklists OR AB checklists)  
S3 (MH "Adult+") OR (MH "Aged+") OR (TI Adult OR AB Adult) OR (TI 
Adults or AB Adults) OR (TI "Young adult" OR AB “Young adult”) OR 




AB “Middle age”) OR (TI "Middle aged" OR AB “Middle aged”) OR 
(TI Elderly OR AB Elderly) OR (TI Elder OR AB Elder) OR (TI 
"Oldest old" OR AB “Oldest old”) OR (TI Nonagenarian OR AB 
Nonagenarian) OR (TI Nonagenarians OR AB Nonagenarians) OR 
(TI Octogenarian OR AB Octogenarian) OR (TI Octogenarians OR 
AB Octogenarians) OR (TI Centenarian OR AB Centenarian) OR (TI 
Centenarians OR AB Centenarians) OR (TI Frail OR AB Frail) 
S4 (MH "Alcohol Withdrawal Delirium") OR (TI "Delirium tremens" OR 
AB "Delirium tremens") OR (TI "Alcohol withdrawal delirium" OR AB 
"Alcohol withdrawal delirium")  
S5 S1 AND S2 AND S3  
S6 S5 NOT S4 
S7 Limit to systematic reviews and meta-analysis 





Web of Science Core Collection 
Platform: Thomson Reuters, Science Citation Index Expanded, 1900-present; 
Social Sciences Citation Index, 1900-present; Arts & Humanities Citation Index, 
1975-present; Conference Proceedings Citation Index-Science, 1990-present; 
Conference Proceedings Citation Index-Social Science & Humanities, 1990-
present; Emerging Sources Citation Index, 2015-present 
Year Limits: Publication Year 1974-Present 
Other Limits: English language 
 
#1 TS=(Delirium OR "Acute confusion" OR "Acute organic brain 
syndrome" OR "Acute confusional state" OR "Acute brain syndrome" 
OR "Acute brain failure" OR "Acute brain dysfunction" OR "Acute 
organic psychosyndrome" OR "Acute organic psycho-syndrome" OR 
"Acute psycho-organic syndrome" OR "Acute psychoorganic 
syndrome" OR "Metabolic encephalopathy" OR "Clouded state" OR 
"Clouding of consciousness") 
#2 TS=(Scale OR Instrument OR Measure OR Questionnaire OR 
Interview OR Evaluation OR Examination OR Exam OR Test OR 
Screening OR Assessment OR Index OR Indices OR Indexes OR 
Checklist OR Tool OR “Qualitative study” OR “Qualitative studies”) 
#3 TS=(Adult OR "Young adult" OR “Young adults” OR "Middle age" OR 
"Middle aged" OR Elderly OR Elder OR “Oldest old” OR 
Nonagenarian OR Octogenarian OR Centenarian OR Frail) 
#4 TS=("Alcohol withdrawal delirium" OR "Delirium tremens" OR 
"Alcohol withdrawal syndrome") 
#5 #1 AND #2 AND #3 
#6 #5 NOT #4 
#7 Limit to systematic reviews and meta-analysis 






Platform: EBSCO, 1880s-Present; ProQuest, 1806-Present  
Year Limits: 01/01/1974 to present 
Other Limits: English language; Adulthood (18 yrs & older) 
 
S1  SU.EXACT("Delirium") OR TI(Delirium) OR AB(Delirium) OR 
TI("Acute confusion") OR AB("Acute confusion") OR TI("Acute 
organic brain syndrome") OR AB("Acute organic brain 
syndrome") OR TI("Acute confusional state") OR AB("Acute 
confusional state") OR TI("Acute brain syndrome") OR AB("Acute 
brain syndrome") OR TI("Acute brain failure") OR AB(“Acute brain 
failure”) OR TI(“Acute brain dysfunction”) OR AB(“Acute brain 
dysfunction”) OR TI("Acute organic psychosyndrome") OR 
AB("Acute organic psychosyndrome") OR TI(“Acute organic 
psycho-syndrome”) OR AB(“Acute organic psycho-syndrome”) 
OR TI("Acute psycho-organic syndrome") OR AB("Acute psycho-
organic syndrome") OR TI(“Acute psychoorganic syndrome”) OR 
AB(“Acute psychoorganic syndrome”) OR TI("Metabolic 
encephalopathy") OR AB("Metabolic encephalopathy") OR 
TI(“Clouded state”) OR AB(“Clouded state”) OR TI(“Clouding of 
consciousness”) OR AB(“Clouding of consciousness”) 
S2 SU.EXACT(“Measurement”) OR SU.EXACT(“Achievement 
Measures”) OR SU.EXACT(“Aptitude Measures”) OR 
SU.EXACT(“Attitude Measurement”) OR SU.EXACT(“Attitude 
Measures”) OR SU.EXACT(“Body Sway Testing”) OR 
SU.EXACT(“Comprehension Tests”) OR SU.EXACT(“Creativity 
Measurement”) OR SU.EXACT(“Criterion Referenced Tests”) OR 
SU.EXACT(“Digit Span Testing”) OR SU.EXACT(“Group 
Testing”) OR SU.EXACT(“Individual Testing”) OR 
SU.EXACT(“Inventories”) OR SU.EXACT(“Multidimensional 
Scaling”) OR SU.EXACT(“Needs Assessment”) OR 
SU.EXACT(“Occupational Interest Measures”) OR 
SU.EXACT(“Perceptual Measures”) OR 
SU.EXACT(“Performance Tests”) OR SU.EXACT(“Preference 
Measures”) OR SU.EXACT(“Projective Testing Technique”) OR 
SU.EXACT(“Psychiatric Evaluation”) OR 
SU.EXACT(“Psychological Assessment”) OR 
SU.EXACT(“Psychometrics”) OR SU.EXACT(“Questionnaires”) 
OR SU.EXACT(“Rating Scales”) OR SU.EXACT(“Retention 
Measures”) OR SU.EXACT(“Screening”) OR 
SU.EXACT(“Screening Tests”) OR SU.EXACT(“Selection Tests”) 
OR SU.EXACT(“Sensorimotor Measures”) OR 
SU.EXACT(“Sociometric Tests”) OR SU.EXACT(“Speech and 




SU.EXACT(“Surveys”) OR SU.EXACT(“Symptom Checklists”) 
OR SU.EXACT(“Testing”) OR SU.EXACT(“Verbal Tests”) OR 
SU.EXACT(“Test Items”) OR SU.EXACT(“Content Analysis 
(Test)”) OR SU.EXACT(“Difficulty Level (Test)”) OR 
SU.EXACT(“Item Analysis (Test)”) OR SU.EXACT(“Item Content 
(Test)”) OR SU.EXACT(“Item Response Theory”) OR 
SU.EXACT(“Rating”) OR SU.EXACT(“Scaling (Testing)”) OR 
SU.EXACT(“Scoring (Testing)”) OR SU.EXACT(“Test 
Administration”) OR SU.EXACT(“Test Bias”) OR 
SU.EXACT(“Test Forms”) OR SU.EXACT(“Test Interpretation”) 
OR SU.EXACT(“Test Reliability”) OR SU.EXACT(“Test 
Standardization”) OR SU.EXACT(“Test Validity”) OR 
SU.EXACT(“Testing Methods”) OR SU.EXACT(“Adaptive 
Testing”) OR SU.EXACT(“Cloze Testing”) OR SU.EXACT(“Essay 
Testing”) OR SU.EXACT(“Forced Choice (Testing Method)”) OR 
SU.EXACT(“Multiple Choice (Testing Method)”) OR 
SU.EXACT(“Q Sort Testing Technique”) OR 
SU.EXACT(“Questionnaires”) OR SU.EXACT(“General Health 
Questionnaire”) OR SU.EXACT(“Interview Schedules”) OR 
SU.EXACT(“Diagnostic Interview Schedule”) OR 
SU.EXACT(“Structured Clinical Interview”) OR 
SU.EXACT(“Interviews”) OR SU.EXACT(“Intake Interview”) OR 
SU.EXACT(“Psychodiagnostic Interview”) OR 
SU.EXACT(“Evaluation”) OR SU.EXACT(“Clinical Audits”) OR 
SU.EXACT(“Geriatric Assessment”) OR SU.EXACT(“Psychiatric 
Evaluation”) OR SU.EXACT(“Self Evaluation”) OR 
SU.EXACT(“Screening”) OR SU.EXACT(“Health Screening”) OR 
SU.EXACT(“Screening Tests”) OR SU.EXACT(“Psychological 
Screening Inventory”) OR SU.EXACT(“Cognitive Assessment”) 
OR SU.EXACT(“Neuropsychological assessment”) OR 
SU.EXACT(“Behavioral Assessment”) OR SU.EXACT(“Likert 
Scales”) OR SU.EXACT(“Test Construction”) OR 
SU.EXACT(“Interviewing”) OR SU.EXACT(“Evaluation Criteria”) 
OR TI(scale) OR AB(scale) OR TI(scales) OR AB(scales) OR 
TI(instrument) OR AB(instrument) OR TI(instruments) OR 
AB(instruments) OR TI(measure) OR AB(measure) OR 
TI(measures) OR AB(measures) OR TI(questionnaire) OR 
AB(questionnaire) OR TI(questionnaires) OR AB(questionnaires) 
OR TI(interview) OR AB(interview) OR TI(interviews) OR 
AB(interviews) OR TI(evaluation) OR AB(evaluation) OR 
TI(evaluations) OR AB(evaluations) OR TI(examination) OR 
AB(examination) OR TI(examinations) OR AB(examinations) OR 
TI(exam) OR AB(exam) OR TI(exams) OR AB(exams) OR 




OR AB(screening) OR TI(screenings) OR AB(screenings) OR 
TI(assessment) OR AB(assessment) OR TI(assessments) OR 
AB(assessments) OR TI(index) OR AB(index) OR TI(indices) OR 
AB(indices) OR TI(indexes) OR AB(indexes) OR TI(checklist) OR 
AB(checklist) OR TI(checklists) OR AB(checklists) 
S3 SU.EXACT("Alcohol Withdrawal”) OR SU.EXACT("Drug 
Withdrawal”) OR TI("Alcohol withdrawal delirium”) OR 
AB("Alcohol withdrawal delirium”) OR SU.EXACT(“Delirium 
Tremens”) OR TI("Delirium tremens”) OR AB("Delirium tremens”)  
S4 S1 AND S2  
S5 S4 NOT S3 
S6 Limit to systematic reviews and meta-analysis 






Platform: Wiley Online Library 
Year Limits: Publication year 1974-present 
Other Limits: Cochrane Reviews, Database of Abstracts of Reviews of Effects 
(DARE), Cochrane Central Register of Controlled Trials (CENTRAL) 
 
#1 [mh Delirium] or "Delirium":ti,ab or "Acute confusion”:ti,ab or "Acute 
organic brain syndrome”:ti,ab or "Acute confusional state”:ti,ab or 
"Acute brain syndrome”:ti,ab or "Acute brain failure”:ti,ab “Acute brain 
dysfunction”:ti,ab or "Acute organic psychosyndrome”:ti,ab or “Acute 
organic psycho-syndrome”:ti,ab or "Acute psycho-organic 
syndrome”:ti,ab or “Acute psychoorganic syndrome”:ti,ab or "Metabolic 
encephalopathy":ti,ab or “Clouded state”:ti,ab or “Clouding of 
consciousness”:ti,ab 
#2 [mh "Psychiatric Status Rating Scales"] or [mh "Neuropsychological 
Tests"] or [mh Psychometrics] or [mh "Mass Screening"] or [mh 
"Geriatric Assessment"] or [mh "Psychological Tests"] or [mh “Surveys 
and Questionnaires”] or [mh "Interview, Psychological"] or [mh 
"Qualitative Research"] or [mh "Mental Status Schedule"] or [mh 
Checklist] or "Scale":ti,ab or "Scales":ti,ab or "Instrument":ti,ab or 
"Instruments":ti,ab or "Measure":ti,ab or "Measures":ti,ab or 
"Questionnaire":ti,ab or "Questionnaires":ti,ab or "Interview":ti,ab or 
"Interviews":ti,ab or "Evaluation":ti,ab or "Evaluations":ti,ab or 
“Exam”:ti,ab or “Exams”:ti,ab or "Examination":ti,ab or 
"Examinations":ti,ab or "Test":ti,ab or "Tests":ti,ab or "Screening":ti,ab 
or "Screenings":ti,ab or "Assessment":ti,ab or "Assessments":ti,ab or 
"Index":ti,ab or "Indices":ti,ab or "Indexes":ti,ab or "Qualitative 
Research":ti,ab or "Qualitative Study":ti,ab or "Qualitative Studies":ti,ab 
or “Checklist”:ti,ab or “Checklists”:ti,ab 
#3 [mh Adult] or [mh "Young Adult"] or [mh Aged] or [mh "Aged, 80 and 
over"] or [mh "Frail Elderly"] or "Adults":ti,ab or "Adult":ti,ab or "Young 
Adults":ti,ab or "Young Adult":ti,ab or "Middle age":ti,ab or "Middle 
aged":ti,ab or "Elderly":ti,ab or "Elder":ti,ab or "Oldest Old":ti,ab or 
"Nonagenarian":ti,ab or "Nonagenarians":ti,ab or "Octogenarian":ti,ab 
or "Octogenarians":ti,ab or "Centenarian":ti,ab or "Centenarians":ti,ab 
or "Frail":ti,ab 
#4 [mh "Alcohol withdrawal delirium"] or "Alcohol withdrawal 
syndrome”:ti,ab or "Delirium tremens”:ti,ab or "Alcohol withdrawal 
delirium":ti,ab 
#5 #1 and #2 and #3 
#6 #5 not #4 
#7 Limit to systematic reviews and meta-analysis 





Table 2.7. COSMIN-guided psychometric review (adapted from RN Jones 
2019) 
 




Effect indicators are influenced by or related to delirium, such 
as signs and symptoms of delirium. Effect indicators are 
appropriate for use in a measurement instrument. Cause or 
formative indicators are factors that might cause delirium (e.g., 
signs of infection), and would not be appropriate to include. 
Studies were given a score of 1 if all items were effect 




Content validity refers to ensuring that all items capture 
relevant aspects of delirium. For instance, this can be 
assessed by face validity reviews involving experts, literature 
reviews, etc. If the study mentioned assessing content validity, 
then it was scored 1 otherwise failure to mention was scored 0. 
Internal 
consistency 
Internal consistency refers to how each item relates to the 
others in the instrument. It is important to make sure the 
instrument assesses a single underlying construct, delirium 
identification. If the authors report internal consistency 
reliability with a value such as Cronbach’s coefficient alpha or 
McDonald’s omega coefficient, then a point was awarded. 
However, if a sample size of less than 50 was used in 
calculating internal consistency they lose ½ point. If the 
authors failed to mention assessment of internal consistency, 
they were awarded no points. 
Inter-rater 
reliability 
Refers to assessments of the agreement between two or more 
raters when making ratings on a single patient or research 
participant. We recorded any mention and statistics given 
including Pearson correlation coefficient, intra-class correlation 
coefficient, or Kappa statistics. If the authors mentioned inter-
rater reliability, they were given a point and deduced a half 
point for using a sample size less than 50. They were given no 




Describes how well and instrument measuring a construct 
correlates with other instruments measuring the same 




was performed, we recorded any correlation coefficients and 
awarded a point. We deducted a half point for using a sample 
size less than 50. They were given no points if they failed to 





refers to comparison of the proposed instrument against a 
reference standard used for delirium case identification. We 
recorded the reference standard and awarded a point if 
assessed. We deducted a half point for using a sample size 
less than 50. They were given no points if they failed to 
mention any reference standard. 
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Table 2.9. List of excluded instruments with reasons 
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Delirium Assessment Scale (DAS) 
Delirium Index (DI) 
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Instruments removed because ICU only: 5 
Cognitive Test for Delirium (CTD) 
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Intensive Care Delirium Screening Checklist (ICDSC) 
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CHAPTER III – Harmonization of Four Delirium Instruments: Creating 
Crosswalks and the Delirium Item-Bank (DEL-IB) 
 
Chapter III is adapted from a manuscript in preparation for submission and 




Objectives: Over 30 instruments are in current, active use for delirium 
identification. In a recent systematic review, we recommended four commonly 
used and well-validated instruments for clinical and research use. The goal of 
this study is to harmonize the four instruments on the same metric using modern 
methods in psychometrics. 
Design: Secondary data analysis from three studies, and a simulation study 
based on the observed data. 
Setting: Hospitalized adults over 65 years old in the United States, Ireland, and 
Belgium. 
Participants: The total sample comprised 600 participants, contributing 1,623 
assessments. 
Measurements: Confusion Assessment Method (long-form and short-form), 
Delirium Observation Screening Scale, Delirium Rating Scale-Revised-98 (total 




Results: Using item response theory, we linked scores across instruments, 
placing all four instruments and their separate scorings on the same metric (the 
propensity to delirium). Kappa statistics comparing agreement in delirium 
identification among the instruments ranged from 0.37-0.75, with the highest 
between the DRS-R-98 total score and MDAS. After linking scores, we created a 
harmonized item bank, called the Delirium Item Bank (DEL-IB), consisting of 50 
items. The DEL-IB allowed us to create six crosswalks, which easily obtain 
equivalent scores across instruments. 
Conclusions: Based on our results, individual instrument scores can be directly 







Delirium is a syndrome characterized by an acute onset of inattention, 
disorientation, and other cognitive disturbances that disproportionately impacts 
adults age 65 and older (12). It has substantial public health impact with 
occurrence in over 2.6 million older Americans, accounting for over $164 billion in 
healthcare expenditures annually (16). The effects can persist long after onset, 
leading to prolonged hospitalization and increased risk of dementia and death 
(15, 16). However, in contrast to its large impact on public health, delirium 
remains understudied (16, 69). Although there are methods to prevent delirium 
(18), there remains no consensus on effective treatments (51). 
 
One potential problem that has stymied progress in the delirium field is the fact 
that there are many methods for the identification of delirium with no direct 
approach to quantify their agreement or correspondence. Measures for 
identification of delirium include instruments for screening and/or diagnosing 
delirium. The lack of a unified approach for identification has led to over 30 
instruments in active use for screening or diagnosis of delirium (8). Delirium 
instruments in active use offer varying assessments that question different signs 
and symptoms inherent to delirium. In our recent systematic review, we selected 
the Confusion Assessment Method (CAM), Delirium Observation Screening 
Scale (DOSS), Delirium Rating Scale-Revised-98 (DRS-R-98), and Memorial 




commonly used, had high quality psychometric validity data, and allowed for 
rating of the reference standard Diagnostic and Statistical Manual of Mental 
Disorders (DSM)-5 criteria (8). 
 
The goal of this paper is to describe the harmonization of four delirium 
identification instruments from our systematic review: the CAM, DOSS, DRS-R-
98, and MDAS. We used three data sources, each of which administered multiple 
instruments to participants with overlapping instruments across data sources 
(i.e., common instruments across data sets), which allowed for harmonization. 
We used modern psychometric methods in portraying how well these instruments 
assess the same underlying concept and describe characteristics of the 
measurement of delirium identification in three samples of older hospitalized 
patients. These methods are used to create an item bank, which is a dataset 
containing each individual instrument’s items and their corresponding estimated 
population level item response theory (IRT) parameters. This item bank is called 




We used three datasets to conduct this study. The first study is the Better 
Assessment of Illness (BASIL) study, which has been described previously (70). 




adults age 70 and older living in or near Boston, MA, USA. The study enrolled 
352 patients between October 20, 2015 and March 15, 2017 who underwent a 
total of 1,187 individual assessments (1-15 daily assessments per participant) 
(70). Each study participant was assessed for delirium with the following four 
instruments: the Confusion Assessment Method (CAM: short-form and long-
form), the Memorial Delirium Assessment Scale (MDAS), the Delirium Rating 
Scale-Revised-98 (DRS-R-98: severity score-first 13 items), and Delirium 
Observation Screening Scale (DOSS: 4 items, specifically items 2, 3, 4, and 12).  
 
The second dataset comes from Detroyer et al. (71). Patients were recruited from 
a palliative care unit in a university hospital in Belgium. A total of 48 patients 
were recruited, who underwent a total of 113 individual assessments. Each 
patient was examined up to three times a day during the first 10 days of their 
hospitalization and was assessed with the full 13-item DOSS and CAM short-
form. 
 
The third dataset comes from Adamis et al. (72). Patients over age 70 admitted 
to acute medical teams in a regional hospital in Ireland were recruited. A total of 
200 patients were enrolled, who underwent a total of 323 individual assessments. 
Each patient was assessed using the DRS-R-98 (total score—all 16 items), and 
CAM short-form. Additionally, this study collected data on DSM-5 and DSM-IV 




used across these 3 datasets; these instruments and items are shown in Figure 
3.1. 
 
Figure 3.1. Data Structure and Models 
Data structure 
BASIL Detroyer et al. Adamis et al. 
CAM Short-form (1) CAM Short-form (1) CAM Short-form (1) 
CAM Short-form (2) CAM Short-form (2) CAM Short-form (2) 
CAM Short-form (3) CAM Short-form (3) CAM Short-form (3) 
CAM Short-form (4) CAM Short-form (4) CAM Short-form (4) 
CAM Short-form (5) CAM Short-form (5) CAM Short-form (5) 
MDAS (1) NA NA 
MDAS (2) NA NA 
MDAS (3) NA NA 
MDAS (4) NA NA 
MDAS (5) NA NA 
MDAS (6) NA NA 
MDAS (7) NA NA 
MDAS (8) NA NA 
MDAS (9) NA NA 
MDAS (10) NA NA 
DRS-R-98 (1) NA DRS-R-98 (1) 
DRS-R-98 (2) NA DRS-R-98 (2) 
DRS-R-98 (3) NA DRS-R-98 (3) 
DRS-R-98 (4) NA DRS-R-98 (4) 
DRS-R-98 (5) NA DRS-R-98 (5) 
DRS-R-98 (6) NA DRS-R-98 (6) 
DRS-R-98 (7) NA DRS-R-98 (7) 




DRS-R-98 (9) NA DRS-R-98 (9) 
DRS-R-98 (10) NA DRS-R-98 (10) 
DRS-R-98 (11) NA DRS-R-98 (11) 
DRS-R-98 (12) NA DRS-R-98 (12) 
DRS-R-98 (13) NA DRS-R-98 (13) 
NA NA DRS-R-98 (14) 
NA NA DRS-R-98 (15) 
NA NA DRS-R-98 (16) 
NA DOSS (1) NA 
DOSS (2) DOSS (2) NA 
DOSS (3) DOSS (3) NA 
DOSS (4) DOSS (4) NA 
NA DOSS (5) NA 
NA DOSS (6) NA 
NA DOSS (7) NA 
NA DOSS (8) NA 
NA DOSS (9) NA 
NA DOSS (10) NA 
NA DOSS (11) NA 
DOSS (12) DOSS (12) NA 
NA DOSS (13) NA 
CAM Short-form (1) = CAM Long-form (1) NA NA 
CAM Short-form (2) = CAM Long-form (2) NA NA 
CAM Short-form (3) = CAM Long-form (3) NA NA 
CAM Short-form (4) = CAM Long-form (4) NA NA 
CAM Short-form (5) = CAM Long-form (5) NA NA 
CAM Long-form (6) NA NA 
CAM Long-form (7) NA NA 
CAM Long-form (8) NA NA 
CAM Long-form (9) NA NA 





Model 1  Model 2  Model 3  Model 4  Model 5  Model 6  Model 7 
BASIL  BASIL  BASIL  BASIL  Detroyer  Adamis  BASIL 
CAM Short-
form (1)  
CAM Short-
form (1)  
CAM Short-
form (1)  
CAM Short-
form (1)  
CAM Short-
form (1)    
CAM Short-form (1) = CAM 
Long-form (1) 
CAM Short-
form (2)  
CAM Short-
form (2)  
CAM Short-
form (2)  
CAM Short-
form (2)  
CAM Short-
form (2)    
CAM Short-form (2) = CAM 
Long-form (2) 
CAM Short-
form (3)  
CAM Short-
form (3)  
CAM Short-
form (3)  
CAM Short-
form (3)  
CAM Short-
form (3)    
CAM Short-form (3) = CAM 
Long-form (3) 
CAM Short-
form (4)  
CAM Short-
form (4)  
CAM Short-
form (4)  
CAM Short-
form (4)  
CAM Short-
form (4)    
CAM Short-form (4) = CAM 
Long-form (4) 
CAM Short-
form (5)  
CAM Short-
form (5)  
CAM Short-
form (5)  
CAM Short-
form (5)  
CAM Short-
form (5)    
CAM Short-form (5) = CAM 
Long-form (5) 
  MDAS (1)  DRS-R-98 (1)  DOSS (2)  DOSS (1)  
DRS-R-98 
(1)  CAM Long-form (6) 
  MDAS (2)  DRS-R-98 (2)  DOSS (3)  DOSS (2)  
DRS-R-98 
(2)  CAM Long-form (7) 
  MDAS (3)  DRS-R-98 (3)  DOSS (4)  DOSS (3)  
DRS-R-98 
(3)  CAM Long-form (8) 
  MDAS (4)  DRS-R-98 (4)  DOSS (12)  DOSS (4)  
DRS-R-98 
(4)  CAM Long-form (9) 
  MDAS (5)  DRS-R-98 (5)    DOSS (5)  
DRS-R-98 
(5)  CAM Long-form (10) 
  MDAS (6)  DRS-R-98 (6)    DOSS (6)  
DRS-R-98 
(6)    
  MDAS (7)  DRS-R-98 (7)    DOSS (7)  
DRS-R-98 
(7)    
  MDAS (8)  DRS-R-98 (8)    DOSS (8)  
DRS-R-98 
(8)    
  MDAS (9)  DRS-R-98 (9)    DOSS (9)  
DRS-R-98 
(9)    
  MDAS (10)  
DRS-R-98 
(10)    DOSS (10)  
DRS-R-98 
(10)    
    
DRS-R-98 
(11)    DOSS (11)  
DRS-R-98 
(11)    
    
DRS-R-98 
(12)    DOSS (12)  
DRS-R-98 
(12)    
    
DRS-R-98 
(13)    DOSS (13)  
DRS-R-98 
(13)    
          
DRS-R-98 
(14)    
          
DRS-R-98 
(15)    
          
DRS-R-98 
(16)    
 
BASIL = Better Assessment of Illness study; Yellow = CAM = Confusion 
Assessment Method; Red = DOSS = Delirium Observation Screening Scale; 
Blue = DRS-R-98 = Delirium Rating Scale-Revised-98; Green = MDAS = 





The darker shaded, non-italicized cells had their parameter estimates freely 
estimated. The lighter shaded, italicized cells had their parameter estimates held 







Four Harmonized Delirium Identification Instruments 
The CAM, DRS-R-98, MDAS, and DOSS are all used to rate delirium signs and 
symptoms either following brief interviews or based upon observations by 
clinicians. While the instruments encompass similar features of delirium, they 
each have unique characteristics. 
  
The CAM long-form consists of 10 items based on the DSM-III-R criteria for 
delirium. The CAM is the only one of these instruments that can be scored using 
a diagnostic algorithm, rather than an additive score. The algorithm requires the 
presence of acute onset and/or fluctuation, inattention, and either disorganized 
thinking or altered level of consciousness (1). The items of the CAM algorithm 
are operationalized to make the CAM short-form. The long-form additionally 
includes the following items: disorientation, memory impairment, perceptual 
disturbances, psychomotor agitation, psychomotor retardation, and altered sleep-
wake cycle. Most CAM features are scored on a three-point scale to give a total 
score on the CAM. Each item is rated 0 (absent), 1 (mild), or 2 (marked), except 
acute onset or fluctuation, which are rated 0 (absent) or 1 (present). For our 
analysis, we used the scoring from the worksheets for the CAM long (scored 0-
20) and short (scored 0-5) forms (73, 74). In the CAM long-form, we coded acute 
onset and fluctuating course as separate variables; thus, our scoring ranges from 




scoring using a single item for acute onset and fluctuating course and the score 
range was 0-19 (4, 75). 
 
The DRS-R-98 instructs assessors to use any accessible information source 
including chart review, nurses, and family to rate and identify delirium according 
to 13 items that characterize severity and an additional 3 diagnostic items. It can 
then be used to score just the severity items, or both the severity items and 
diagnostic items combined. The severity items are in order: sleep/wake cycle 
disturbance, perceptual disturbances and hallucinations, delusions, lability of 
affect, language, thought process abnormalities, motor agitation, motor 
retardation, orientation, attention, short-term memory, long-term memory, and 
visuospatial ability (76). The diagnostic items are temporal onset of symptoms, 
fluctuation of symptom severity, and physical disorder. The ratings for each item 
range from 0 (no impairment) to 3 (severe impairment), except for fluctuation of 
symptom severity and physical disorder, which are both rated 0 to 2. The DRS-R-
98 total score (16 items) ranges from 0 to 46 with an author-defined cut score of 
17.75 for defining presence of delirium and the DRS-R-98 severity score (13 
items) ranges from 0 to 39 with an author-defined cut score of 15.25 for defining 
presence of delirium. 
 
The DOSS instructs assessors to rate delirium using 13 items on a binary scale 




likely has delirium (38, 77, 78). The instrument was designed to be administered 
by bedside nurses once per shift through observation of verbal and nonverbal 
behaviors. Items include: dozes off during conversation or activities; is easily 
distracted by stimuli from the environment; maintains attention to conversation or 
action; does not finish question or answer; gives answers that do not fit the 
question; reacts slowly to instructions; thinks they are somewhere else; knows 
which part of the day it is; remembers recent events; is picking, disorderly, 
restless, pulls intravenous (IV) tubing, feeding tubes, catheters etc.; is easily or 
suddenly emotional; and sees/hears things which are not there (38). 
 
The MDAS uses a four-point scale (0 to 3) for each of its 10 items (24). The 
instrument items were selected based on DSM-IV criteria and include in order: 
reduced level of consciousness, disorientation, impaired short-term memory, 
impaired digit span, reduced ability to maintain and shift attention, disorganized 
thinking, perceptual disturbance, delusions, psychomotor activity, and sleep-
wake cycle disturbances. The MDAS ranges from 0 to 30 with an author-defined 
cut score of 13 for defining presence of delirium. 
 
Data Analysis: Harmonization 
Harmonization is a form of test score linking that enables the transformation of 
data from multiple sources in a comparable way such that they can be treated as 




datasets including the Health and Retirement Study to other similar cross-
national studies (79). Our approach involved the use of item response theory 
(IRT)-based co-calibration of the four instruments. Instrument metrics are linked 
through the presence of common (linking) items available across studies. Linking 
items are items that are or can be assumed to be equivalent across studies. Our 
approach involves the assumption that all instruments measure the same 
underlying trait. 
 
IRT describes a large body of latent variable models used to describe 
relationships between the latent trait that underlies the instrument and the 
responses to the individual items that comprise the instrument (i.e., the item 
responses). In our analysis, the latent trait is conceptualized as the propensity to 
delirium; the item responses are generated from the individual questions on the 
delirium identification instruments, which assess the signs and symptoms of 
delirium. We use IRT to harmonize all instruments from the different datasets, 
allowing for their comparison on the same metric. We fit a graded response 
model, which estimates a discrimination parameter and boundary (difficulty) 
parameters between response categories. The discrimination parameter 
describes how well each item separates individuals of low and high levels of the 
latent trait (27, 43). The boundary, or difficulty, parameters identify the level on 




response category (27, 43, 80). The collection of item parameters for all items 
comprises the item bank. 
 
To perform the statistical harmonization, we used IRT-based generalized 
structural equation models, and chose unidimensional factor models since their 
fit was considered adequate and appropriate for our aims. Then, we matched 
instruments on the same metric using a combination of the anchor-test design 
and common-person design (43). In the anchor-test design, common items are 
administered to different study populations. For example, in our study, four 
questions of the DOSS were given in the BASIL sample, while all of the 
questions were given in the Detroyer et al. sample, allowing us to link the 
instruments. In the common-person design, common instruments are given to 
different study populations. In our study, the CAM short-form was given across 
every dataset. In total, we fit seven different models using the generalized 
structural equation modeling procedures in Stata (version 16.1, College Station, 
Texas) to estimate item parameters. The structure of our models is shown in 
Figure 3.1. To accomplish the harmonization, we constrained (i.e., held 
constant) item parameters on items that were in common across different models 
to link all the instruments.  
 
To summarize our approach, we have shown each of the designs of our models 




We began with the CAM short-form items being held constant in the models, 
since these were constant across all datasets. We first estimated an IRT model 
to find the item parameters in the CAM short-form using participants from the 
BASIL study. Second, we held the CAM short-form parameters from the first 
model constant, and freely estimated all MDAS items from the BASIL study. 
Third, we again held the CAM short-form parameters from the first model 
constant, and freely estimated the 13 items in the DRS-R-98 severity score from 
the BASIL study. Fourth, we held the CAM short-form parameters constant, and 
freely estimated the 4 items from the DOSS found in the BASIL study 
(specifically DOSS items 2, 3, 4, and 12). Fifth, we held the parameters from 
CAM short-form and 4 items from the DOSS found in the BASIL study constant, 
and freely estimated the remaining DOSS items from the Detroyer et al. dataset. 
Sixth, we held the parameters from CAM short-form and 13 items in the DRS-R-
98 severity score found in the BASIL study constant, and freely estimated the 
remaining 3 items from the DRS-R-98 total score found in the Adamis et al. 
dataset. Seventh, we held the CAM short-form parameters constant, and freely 
estimated the CAM long-form items from the BASIL study. 
 
In all datasets, items that were coded as “uncertain” or “don’t know” were set to 
missing. If at least one item was non-missing for a person-visit, that person-visit 






To generate our crosswalks between instruments, we used simulation 
procedures based on our observed data. For this simulation, our goal was to 
generate a single large sample of persons and their item responses to all of the 
delirium assessment items in our item bank, the DEL-IB. We wanted to generate 
a hypothetical cohort that was large enough (>100 times the size of our 
combined cohort in this study) to have demonstrated scores on all instrument 
items included in the DEL-IB. Boundary parameter estimates not observed in the 
real data were extrapolated from observed parameter estimates. We created the 
simulated dataset using the R-based program Firestar (81). We input our item 
parameters already found in the DEL-IB and had the program create a simulated 
sample size of N=100,001, with each participant responding to each item in the 
DEL-IB. The underlying latent trait was weighted to a normal distribution with an 
assumed mean of 0 and standard deviation of 1. We used these responses to 
generate expected score characteristic curves and crosswalks for all measures. 
Expected score characteristic curves are the curves made from the parameter 
estimates in the DEL-IB. 
 
Crosswalks are a representation of equivalent scores on different instruments. 
We used similar methods to create reliability or measurement precision curves, 
which reveal the level of accuracy with which a given instrument measures the 






The total sample size was 600 participants, who contributed 1623 unique 
assessments. Table 3.1 describes the study characteristics across the three 
studies. The BASIL study and Adamis et al. study had study populations with 
mean age over 80 years and balanced participant genders. The Detroyer et al. 
study had a younger study population with median age of 72, and 38% of the 
study population was female. The rates of delirium across the studies based on 
CAM criteria, which was in common across all the studies, ranged from 17%-
25%. Notably, the Adamis et al. study had a high prevalence of patients with 
dementia (63%). 
 






Adamis et al. 
(N=200) 
Age, years, mean (SD) or 
median (IQR) 
80.3 (6.8) 72 (67.25; 
78) 
81.1 (6.5) 
Female sex, n (%) 203 (58) 18 (38) 100 (50) 
Non-white race, n (%) 48 (14) NR NR 
Years of education, mean 
(SD) 
14.5 (3.0) NR NR 
Married, n (%) 139 (40) 26 (54) NR 
Lives alone, n (%) 135 (39) 7 (15) NR 
Lives in nursing home, n (%) 13 (3.7) 1 (2.1) NR 
Dementia/previous history of 
cognitive impairment, n (%) 
101 (29) NR 126 (63) 
CAM delirium (ever), n (%) 88 (25) 11 (23) 34 (17) 
NR = not reported; SD = standard deviation; IQR = interquartile range; BASIL = 






Table 3.2 are the kappa statistics of agreement in delirium identification between 
the instruments using their author-described definitions. The range in kappa 
statistics was 0.37-0.75. This range describes agreement that is considered fair 
to substantial (82). The highest levels of agreement were between the DRS-R-98 
total score and MDAS with kappa=0.75. 
 
Table 3.2. Kappa statistics of delirium identification between CAM (short), 
DOSS, DRS-R-98, MDAS 
  CAM (short) DOSS MDAS 
        
DOSS .61  ---  --- 
MDAS .56 .37  --- 
DRS-R-98 (severity) .70 .53 .69 
DRS-R-98 (total) .63 .44 .75 
CAM = Confusion Assessment Method (short-form); DOSS = Delirium 
Observation Screening Scale; DRS-R-98 = Delirium Rating Scale-Revised-98; 
MDAS = Memorial Delirium Assessment Scale 
 
Kappa values can be interpreted as slight for .01-.20, fair for .21-.40, moderate 
for .41-.60, substantial for .61-.80, and almost perfect agreement for .81-1.0 (83). 
 
In Figure 3.2, we show the expected score characteristic curves for each of the 
instruments. In Figure 3.2, we display the expected score on each instrument at 
different levels along the latent trait. At low levels of the latent trait, there are few 




trait increases and participants have a higher propensity to delirium, more signs 
and symptoms are endorsed and scores increase. 
 
Figure 3.2. Expected score characteristic curves of each delirium 
identification instrument 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening 
Scale; DRS-R-98 = Delirium Rating Scale-Revised-98; MDAS = Memorial 
Delirium Assessment Scale 
 
Figure Legend: Expected score characteristic curves of each delirium 
identification instrument are shown. Each curve shows the expected proportion of 
total points a participant would have on each instrument across the latent trait, 






Figure 3.3 shows the reliability of each delirium identification instrument. These 
curves show the varying reliability of each instrument across different levels of 
the latent trait, propensity to delirium. Each of the curves has a peak reliability 
that falls on the latent trait at roughly the same level, between 1.5-2.0. 
 
Figure 3.3. Reliability of each delirium identification instrument 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening 
Scale; DRS-R-98 = Delirium Rating Scale-Revised-98; MDAS = Memorial 
Delirium Assessment Scale 
 
Figure Legend: Measurement reliability or precision of each different delirium 






As shown in Figure 3.2, by aligning the expected score characteristic curves of 
each instrument on the same latent trait, we are able to make equivalent scores 
across each instrument to generate the crosswalks, as shown in Table 3.3 
through Table 3.8. For integer scores, crosswalks only work in a single 
direction; thus, it is important to use the proper one when comparing or 
transforming scores from one instrument to another. Each table can be read by 
starting with the source instrument in the first column and moving along the row 
to see the equivalent score on each of the other 5 instruments, as well as where 









Table 3.3. DOSS crosswalk 
Source 
Instrument 
 Equivalent Scores 












0  0 0 0 1 0 -4.3 
1  1 2 3 4 3 -0.3 
2  1 3 5 7 5 0.6 
3  2 5 6 10 8 1.0 
4  3 7 8 13 11 1.2 
5  3 8 10 15 12 1.5 
6  3 9 11 17 14 1.8 
7  4 10 13 20 16 2.0 
8  4 12 15 22 18 2.2 
9  4 13 17 25 21 2.6 
10  5 14 20 29 24 3.0 
11  5 16 22 33 28 3.5 
12  5 18 26 40 33 4.7 
13   5 19 29 44 38 8.5 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening Scale; DRS-R-98 = Delirium 














 Equivalent Scores 
CAM Short-form   CAM Long-form DOSS MDAS 
DRS-R-98 
Total 
DRS-R-98 Severity Latent Trait 
0  0 0 0 1 0 -4.2 
1  2 1 3 5 4 0 
2  4 2 6 9 7 0.9 
3  8 5 10 15 13 1.6 
4  12 8 15 23 19 2.3 
5   19 13 28 44 37 7.3 
 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening Scale; DRS-R-98 = Delirium 










Table 3.5. CAM Long-form crosswalk 
Source 
Instrument 
 Equivalent Scores 






0  0 0 0 0 0 -5.2 
1  0 0 1 1 1 -2.8 
2  0 1 2 3 3 -0.3 
3  1 1 4 6 5 0.3 
4  1 2 5 8 6 0.7 
5  2 3 6 10 8 0.9 
6  2 3 8 12 10 1.2 
7  3 4 8 13 11 1.4 
8  3 5 10 15 13 1.5 
9  3 6 11 17 14 1.8 
10  4 7 13 20 16 2.0 
11  4 8 14 22 18 2.1 
12  4 8 16 23 19 2.4 
13  4 10 18 26 21 2.6 
14  5 10 20 29 24 2.9 
15  5 11 21 31 26 3.2 
16  5 11 23 35 29 3.6 
17  5 12 25 38 32 4.3 
18  5 13 27 41 35 5.2 








20   5 13 29 45 38 9.5 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening Scale; DRS-R-98 = Delirium 













 Equivalent Scores 
DRS-R-98 
Severity 




0  0 0 0 0 0 -5.3 
1  0 1 0 1 1 -3.2 
2  0 1 0 2 2 -0.9 
3  1 2 1 3 4 -0.3 
4  1 2 1 3 5 0.0 
5  1 3 1 4 6 0.3 
6  1 3 2 4 7 0.5 
7  2 4 2 5 8 0.7 
8  2 5 2 6 9 0.9 
9  2 5 3 7 11 1.0 
10  2 6 3 8 12 1.2 
11  3 7 4 8 13 1.3 
12  3 8 4 9 14 1.5 
13  3 8 5 10 16 1.6 
14  3 9 6 11 17 1.7 
15  4 10 6 12 19 1.9 
16  4 10 7 13 20 2.0 
17  4 11 7 14 21 2.1 








19  4 12 8 16 23 2.4 
20  4 13 9 16 25 2.5 
21  4 13 9 17 25 2.6 
22  5 14 10 18 27 2.7 
23  5 14 10 20 29 2.9 
24  5 14 10 20 29 3.0 
25  5 15 10 21 31 3.1 
26  5 16 11 21 32 3.3 
27  5 16 11 22 33 3.4 
28  5 16 11 23 34 3.5 
29  5 17 12 23 36 3.7 
30  5 17 12 24 37 4.0 
31  5 17 12 24 37 4.1 
32  5 18 12 25 39 4.4 
33  5 18 12 26 40 4.7 
34  5 19 13 27 41 5.2 
35  5 19 13 28 42 5.7 
36  5 19 13 28 43 6.1 
37  5 19 13 28 44 8.0 
38  5 20 13 29 45 9.5 
39   5 20 13 29 45 10.3 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening Scale; DRS-R-98 = Delirium 













 Equivalent Scores 




0  0 0 0 0 0 -5.4 
1  0 1 0 1 1 -3.4 
2  0 1 0 1 1 -1.7 
3  0 1 0 1 1 -1.1 
4  1 2 1 3 3 -0.3 
5  1 2 1 3 4 0.1 
6  1 3 1 4 5 0.3 
7  1 3 1 4 6 0.5 
8  1 4 2 5 6 0.6 
9  2 4 2 5 7 0.8 
10  2 5 3 6 8 0.9 
11  2 5 3 7 9 1.1 
12  2 6 3 8 10 1.2 
13  3 7 4 8 11 1.3 
14  3 7 4 9 12 1.4 
15  3 8 5 10 13 1.5 
16  3 8 6 11 14 1.7 
17  3 9 6 11 14 1.7 








19  4 10 7 13 16 1.9 
20  4 10 7 13 16 2.0 
21  4 11 7 14 17 2.1 
22  4 11 8 15 18 2.2 
23  4 12 8 16 19 2.3 
24  4 13 9 16 20 2.4 
25  4 13 9 17 20 2.5 
26  5 13 10 18 22 2.6 
27  5 14 10 18 22 2.7 
28  5 14 10 19 23 2.8 
29  5 14 10 20 24 2.9 
30  5 15 10 20 25 3.1 
31  5 15 11 21 26 3.2 
32  5 15 11 21 26 3.3 
33  5 16 11 22 27 3.4 
34  5 16 11 23 28 3.6 
35  5 16 11 23 29 3.7 
36  5 17 12 24 30 3.9 
37  5 17 12 24 31 4.1 
38  5 17 12 25 32 4.3 
39  5 18 12 26 33 4.6 
40  5 18 13 26 34 4.9 
41  5 18 13 27 35 5.3 
42  5 19 13 28 36 6.1 








44  5 19 13 28 37 8.2 
45  5 20 13 29 38 9.6 
46   5 20 13 29 38 10.4 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening Scale; DRS-R-98 = Delirium 














 Equivalent Scores 












0  0 0 0 0 0 -5.4 
1  0 1 0 1 0 -3.4 
2  0 1 0 2 1 -1.0 
3  1 2 1 4 3 -0.2 
4  1 2 1 5 4 0.2 
5  1 3 2 7 5 0.5 
6  2 4 2 9 7 0.8 
7  2 5 3 10 8 1.0 
8  3 6 3 12 10 1.2 
9  3 7 4 14 12 1.4 
10  3 8 5 15 13 1.6 
11  3 9 6 17 14 1.7 
12  4 10 6 19 15 1.8 
13  4 10 7 20 16 2.0 
14  4 11 7 21 17 2.1 
15  4 12 8 22 18 2.3 
16  4 12 9 24 20 2.4 
17  4 13 9 25 21 2.6 








19  5 14 10 28 23 2.9 
20  5 15 10 31 25 3.0 
21  5 15 11 31 26 3.2 
22  5 16 11 33 27 3.4 
23  5 16 11 35 29 3.7 
24  5 17 12 37 31 4.0 
25  5 18 12 39 32 4.4 
26  5 18 12 40 34 4.8 
27  5 19 13 42 36 5.6 
28  5 19 13 44 37 7.9 
29  5 20 13 45 38 9.4 
30   5 20 13 45 38 10.1 
 
CAM = Confusion Assessment Method; DOSS = Delirium Observation Screening Scale; DRS-R-98 = Delirium 







We used modern psychometric methods including IRT to harmonize the CAM, 
DRS-R-98, DOSS, and MDAS on the same metric. Using three independent data 
sets, we were able to cross-link four instruments for delirium identification, using 
the common CAM short-form items as an anchor. We created crosswalks of 
scores, putting all the instruments on the same metric using IRT approaches. 
Importantly, we generated the DEL-IB with 50 items, which includes individual 
items scores and their population-based parameter estimates. The DEL-IB will 
provide an important resource for future work.  
 
Harmonization of four commonly used and well-validated instruments represents 
a substantial advance for the field. Currently, when studies use different delirium 
instruments, delirium rates may vary across studies, resulting in the potential for 
flawed or misleading conclusions. The DEL-IB allowed for the creation of 
crosswalks that permit direct comparison of the delirium identification instrument 
scores across the instruments we harmonized. The crosswalks will allow 
comparison of scores on different instruments in real time. For example, a nurse 
presents a patient’s DOSS score to the consulting psychiatrist, who will be able 
to determine an equivalent score on the DRS-R-98, with which the psychiatrist 





Our study, by applying advanced measurement methods to compare 
instruments, is relatively novel within the field of delirium research. The only other 
known use of harmonization of delirium instruments was performed previously 
using only the BASIL study to harmonize the measurement of delirium severity 
(84). In the previous harmonization work, the BASIL study was used to 
harmonize the CAM (short-form and long-form), DRS-R-98 (severity score only), 
and MDAS (84). Thus, our study extends this work to delirium identification 
instruments, and now includes the CAM short and long-forms, the DRS-R-98 
severity and total score, and the DOSS, using three separate datasets from 
different geographic regions.  
 
There are several strengths to this study. This study used a novel approach 
within delirium research, namely the application of advanced psychometric 
methods to the three independent datasets, each examining multiple delirium 
identification instruments. Additionally, these datasets examine patients from the 
United States, Ireland, and Belgium, enhancing the generalizability of the results. 
Each site provided multiple ratings on a robust number of participants. The fact 
that each of these institutions used multiple and overlapping delirium 
identification measures facilitated the work. The inclusion of DSM-5 reference 





There are several limitations that deserve comment. First, since each of the 
datasets were derived from hospitalized patients, the results might not be 
generalizable to non-hospital settings. Second, the data was collected using 
various approaches, including clinical bedside observations by nurses and 
clinicians at two sites, and trained lay interviewers at another sites. Both of these 
approaches may have varied in comparison with reference standard-quality 
ratings by expert clinicians, such as geriatricians or geriatric psychiatrists. Third, 
our comparisons are based on simulation data, instead of real data on all four 
instruments simultaneously administered to each patient within a single study 
that might yield different or stronger psychometric evidence. 
 
Crosswalks will allow comparison of equivalent delirium rates across different 
studies and enable pooling of data from multiple studies, regardless of the 
delirium identification measure used. Such pooling will facilitate combining of 
data across multiple studies for meta-analyses and creation of big data resources 
with integrative analyses of pooled data to advance studies in omics, delirium 
pathophysiology, machine learning or other areas requiring large samples. 
Future directions include delving into applications of the created DEL-IB, such as 
comparing author-defined cut-points for case identification. Additionally, the DEL-
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CHAPTER IV – Delirium Item Bank (DEL-IB): Utilization to Evaluate and 
Create Delirium Instruments 
 
Chapter IV is adapted from a manuscript in preparation for submission and 
included with permission not required. 
 
Abstract 
Background: The large number of heterogeneous instruments in active use for 
identification of delirium prevents direct comparison of studies and the ability to 
combine results. In a recent systematic review we performed, we 
recommended four commonly used and well-validated instruments and 
subsequently harmonized them on the same metric using advanced 
psychometric methods to develop an item bank, the Delirium Item Bank (DEL-
IB). 
Objectives: The goal of the present study is to find optimal cut-points on each 
instrument and to demonstrate use of the DEL-IB to create new instruments. 
Methods: We used a secondary analysis and simulation study based on data 
from three previous studies of hospitalized older adults (age 65+ years) in the 
United States, Ireland, and Belgium. The combined dataset included 600 
participants, contributing 1,623 delirium assessments. The measurements 
included the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition 




(long-form and short-form), Delirium Observation Screening Scale (DOSS), 
Delirium Rating Scale-Revised-98 (DRS-R-98) (total and severity scores), and 
Memorial Delirium Assessment Scale (MDAS). 
Results: We identified different cut-points for each instrument to optimize 
sensitivity or specificity, and Youden’s J statistic, and compared instrument 
performance at each cut-point to the author-defined cut-point. For example, 
the cut-point on the MDAS at Youden’s J statistic was at a sum score of 6 with 
89% sensitivity and 79% specificity. Then, using the DEL-IB, we created four 
example instruments (two short forms and two long forms) and evaluated their 
performance characteristics. In the first example short form instrument, the 
cut-point at Youden’s J statistic was at a sum score of 3 with 90% sensitivity, 
81% specificity, 30% positive predictive value (PPV), and 99% negative 
predictive value (NPV). 
Conclusion: We used the DEL-IB to better understand the psychometric 
performance of 6 current delirium identification instruments and scorings, and 
demonstrated its use to create new instruments. Ultimately, we hope the DEL-
IB might be used to create optimized delirium identification instruments and to 






Delirium is a public health problem that disproportionately impacts older adults. 
Delirium is estimated to occur in over 2.6 million older (age 65+ years) Americans 
annually, and accounts for over $164 billion in healthcare expenditures (16). 
Unfortunately, despite its large public health impact, delirium remains 
understudied (16, 69). Clinically, delirium is characterized by an acute onset of 
inattention, disorientation, and other cognitive disturbances and is diagnosed 
based on clinical observations. Its effects can persist beyond the acute event 
leading to prolonged hospitalization, producing an increased risk of dementia and 
death (15, 16). Fortunately, effective approaches have been developed to 
prevent delirium (18). However, due to the reliance on bedside clinical diagnosis 
without specific laboratory markers or radiographic evidence, there is no 
consensus on a single, effective approach for delirium identification (51). 
 
This lack of consensus has led to the use of a large number of instruments for 
identification of delirium, which in turn, has hampered progress of the field. Many 
of these instruments have been created without full understanding about their 
performance characteristics across different populations, or of their agreement 
with each other. There are at least 30 instruments in current use for identifying 
delirium (e.g., for screening or diagnosis purposes) and each of these 
instruments provide varying degrees of coverage of delirium domains (8). Based 




selected the Confusion Assessment Method (CAM), Delirium Observation 
Screening Scale (DOSS), Delirium Rating Scale-Revised-98 (DRS-R-98), and 
Memorial Delirium Assessment Scale (MDAS) as the instruments that were the 
most commonly used, that had high quality psychometric validity data, and that 
best fulfilled Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 
criteria for delirium (8). 
 
Following the systematic review, we harmonized the four selected instruments on 
the same metric using modern methods in psychometrics to develop a 
harmonized item bank, the Delirium Item Bank (DEL-IB), and to create 
crosswalks between the scores on all four instruments [See Chapter III]. We 
used three separate datasets (70-72), each containing multiple instruments 
administered to participants, which overlapped and allowed for harmonization of 
the items on the same metric, that is, the propensity to delirium. An item bank is 
a dataset that contains each item on each instrument, along with their estimated 
population level item response theory (IRT) parameters. Crosswalks provide an 
easy-to-use guide with corresponding scores on different instruments and can be 
readily used to cross-reference scores in real time across multiple instruments. 
 
The goals of the present manuscript are twofold. First, we wanted to determine 
the cut-points that would best identify delirium in comparison with a common 




to create new instruments and to demonstrate their performance characteristics 
using the selected cut-points. Thus, we aimed to demonstrate how the use of the 
DEL-IB can be used to develop and evaluate multiple new delirium instruments 
to advance the field. 
 
Methods 
Study Samples.  
We previously described the study samples and the preliminary creation of the 
DEL-IB [See Chapter III]. Briefly, we used data from three studies: Adamis et al. 
(n=200) (72), BASIL (Better Assessment of Illness Study) (n=352) (70), and 
Detroyer et al. (n=48) (71) each administering multiple and at least partially 
overlapping delirium identification instruments to hospitalized adults age 65 years 
and older. The total sample for the present analysis included 600 participants, 
contributing 1,623 delirium assessments. The instruments included across the 
studies are: Confusion Assessment Method (CAM) (long-form and short-form), 
Delirium Observation Screening Scale (DOSS), Delirium Rating Scale-Revised-
98 (DRS-R-98) (total and severity scores), and Memorial Delirium Assessment 
Scale (MDAS). 
 
Overall Analytic Approach.  
We used item response theory (IRT) to perform statistical harmonization, to 




harmonization provides a quantitative approach to cross-link each item of each 
instrument on the same latent trait metric, in this case, propensity to delirium. 
Taken together, the items and their parameter estimates comprised the DEL-IB, 
created in our prior study [See Chapter III], which serves as the foundation for 
the present study.  
 
Our first step in the present analysis was to identify cut-points on the four 
selected instruments. We started with the Adamis et al. study where the CAM 
and DRS-R-98 scores were related to DSM-5-defined delirium diagnoses, which 
was used as the reference standard (11). We then repeated these procedures 
using summary scores derived from the MDAS and DOSS, plus alternative 
versions of the CAM and DRS-R-98, by linking common items across studies and 
relating their performance to DSM-5-defined delirium diagnoses. We used 
simulation methods based on the Adamis et al. results and IRT results from our 
prior harmonization work [See Chapter III]. Our first goal was to determine cut-
points that best identified presence (versus absence) of delirium through 
simulation studies on our secondary data sources. We estimated three different 
cut-points on each instrument: one cut-point to optimize sensitivity (>90% 
sensitivity), one to optimize specificity (>90% specificity), and one that balanced 
sensitivity and specificity at Youden’s J statistic (85). We compared instrument 
performance at these cut-points with the author-defined cut-points and with 





To illustrate how the DEL-IB could be used to create new instruments, we 
generated four different examples. We aimed to first create short forms, selecting 
5 items as a maximum for streamlined use in clinical practice. The first short form 
selected items to optimize content validity; the second short form selected items 
with maximum information at the optimal level on the latent trait for identifying 
DSM-5 delirium. Similarly, two long-forms were created with 10 items each. 
Again, the first long form selected items to optimize content validity; the second 
long form selected items with maximum information by IRT. 
 
Data Analysis: Cut-points 
Adamis et al. used DSM-5 criteria to diagnose delirium, and assessed each 
patient simultaneously using the CAM and full DRS-R-98. Since the DEL-IB 
contained the CAM and DRS-R-98 and Adamis et al. included these instruments 
alongside the reference standard diagnosis of DSM-5, we were able to generate 
a latent trait estimate for delirium symptom data. Using logistic regression, we 
developed a prediction model for DSM-5 reference standard delirium diagnosis 
given the latent trait estimate. We simulated a dataset of 100,001 observations 
applying the R-based program Firestar (81), using the existing parameter 
estimates across all six different instrument scorings in the DEL-IB. Then, we 
added the DSM-5-defined delirium diagnoses to this dataset applying the 




scores across all six different instrument scorings in the new simulated data. 
Then, we related the total scores, author’s cut-points, and identified cut-points 
that optimized sensitivity nearest to 90%, specificity nearest to 90%, and at 
Youden’s J cut-score on each of the original instruments. We also looked at the 
latent trait estimate used in the item generating models in terms of sensitivity 
nearest to 90%, specificity nearest to 90%, and Youden’s J statistic. Youden’s J 
statistic is based on the formula:  
J = sensitivity + specificity – 1, 
and therefore, defined for all points along the ROC curve; the cut-point that 
returns the maximum J statistic is the one that maximizes both sensitivity and 
specificity at the same time (85). For all analyses, we used direct standardization 
to the BASIL sample CAM short form distribution to account for sample 
heterogeneity (86). We used Stata (version 16.1, College Station, Texas) in all of 
our analyses to develop our IRT models and receiver operator characteristic 
(ROC) curves. 
 
Each instrument has different methods the author used to describe likelihood of 
delirium identification. The CAM (both short and long forms) defines delirium 
using a diagnostic algorithm (1). The DOSS defines delirium as a score ≥3 (38, 
77, 78). The MDAS defines delirium as a score ≥15 (24). The DRS-R-98 severity 
and total defines delirium as a score >15.25 and >17.75 on its 13-item severity 





Data Analysis: New Instruments 
To demonstrate its application, we used the DEL-IB to create four new 
instruments, two short forms and two long forms. In creating our instruments, we 
wanted to select items that matched domains relevant to DSM criteria. The 
delirium identification domains defined from the DSM-5 diagnostic criteria, based 
on a previous expert panel process by our group included: acute onset, 
fluctuating course, inattention, disorientation, and cognitive impairment (8). The 
expert panel also rated other delirium identification domains covered by DSM-
diagnostic criteria from earlier versions of the DSM, including DSM-III (when 
delirium was first codified), DSM-III-R, DSM-IV, and DSM-IV-TR. In addition to 
the five domains already defined, there were five additional domains identified, 
which included: (i) level of consciousness, (ii) disorganized thinking, (iii) 
psychomotor agitation, (iv) psychomotor retardation, and (v) hallucinations, 
perceptual disorder or distortion (8). Based on the previous expert panel process 
(8), each item of the CAM, DOSS, DRS-R-98, and MDAS items were matched to 
these domains. 
 
The first example instrument is a short form (5 items) with highest content 
validity. To achieve this, items were selected based on the following criteria: 




we identified the item with the highest information content at a latent trait level 
that maximized the Youden’s J statistic for DSM-5 delirium. 
 
The statistical notion of information is defined as the inverse of precision (87). In 
the IRT context, item information refers to the inverse of the precision with which 
a particular item provides for estimating an individual's level on the underlying 
trait upon which the item responses are believed to be based (88). Information is 
operationalized as the inverse variance of an item response function and is 
computed on the basis of the estimated item response parameters 
(discrimination, difficulty or location) (89). Precision is not constant across the 
range of the latent trait; it is peaked at the level of the underlying trait where the 
difficulty or boundary parameters are located. As inverse variance estimates, 
information functions are additive across all items in an instrument. The sum of a 
set of items’ information functions, known as test information, conveys the 
accuracy with which a set of items measures an underlying trait. Among the 
items in the DEL-IB, we used item information functions to identify, among the 
items in the DEL-IB, those that provide the most information in the region of the 
underlying trait that corresponds to the cut point that optimizes sensitivity and 
specificity for DSM-5 delirium. We also used test information functions to assess 
the quality of measurement of an instrument. The IRT notion of reliability can be 
expressed as a function of test information: reliability is the complement of the 




making would have a reliability of at least 0.90 (91), then the target test 
information level – particularly in regions of the latent trait important for making 
individual level decisions – should be at least 10. 
 
The second example instrument is a short form that includes the five items with 
the highest information only, without regard for content balancing. The third 
example instrument is a long form (10 items) that includes one item from each of 
the 10 domains of delirium identification across all versions of the DSM, which 
was also selected by the same criteria as the first example instrument. Within 
each of the 10 domains of the DSM-defined delirium diagnostic criteria, we 
identified the item that has the highest information content at a latent trait level 
that maximized the Youden’s J statistic with respect to DSM-5 delirium. The 
fourth example instrument is another long form that includes the 10 items with 
the highest information only, without regard for content balancing. 
 
Results 
Across all three studies there were 1623 unique assessments provided by 600 
participants. The description of the study characteristics across each of the three 
studies is shown in Table 4.1. The study samples of the Adamis et al. and BASIL 
study each had comparable rates on participant sex and mean age over 80 
years, while the Detroyer et al. study, with a smaller sample size (n=48), had 




prevalence (63%) of patients with dementia. The prevalence of CAM-defined 
delirium across the studies ranged from 17%-25%. The Adamis et al. sample, 
which provided the basis for the simulation study, had a 13% prevalence of 
delirium by DSM-5 criteria. This lower prevalence of delirium was adjusted by 
use of direct standardization techniques, as described in the methods section 
(86). 
 









Age, years, mean (SD) or median 
(IQR) 




Sex:     
Female sex, n (%) 100 (50) 203 (58) 18 (38) 
Male sex, n (%) 100 (50) 149 (42) 30 (62) 
Race:     
White race, n (%) NR 304 (86) NR 
Non-white race, n (%) NR 48 (14) NR 
Years of education, mean (SD) NR 14.5 
(3.0) 
NR 
Married, n (%) NR 139 (40) 26 (54) 
Lives alone, n (%) NR 135 (39) 7 (15) 
Lives in nursing home, n (%) NR 13 (3.7) 1 (2.1) 
Dementia status:    
Dementia or history of cognitive 
impairment, n (%) 
126 (63) 101 (29) NR 
No dementia or history of 
cognitive impairment, n (%) 
74 (37) 251 (71) NR 
CAM delirium (ever), n (%) 34 (17) 88 (25) 11 (23) 
DSM-5-defined delirium diagnosis, n 
(%) 
26 (13) NR NR 
NR = not reported; SD = standard deviation; IQR = interquartile range; BASIL = 
Better Assessment of Illness Study; CAM = confusion assessment method; DSM-






Figure 4.1 shows ROC curves for each of the six delirium identification 
instruments and for the latent trait, propensity to delirium, using DSM-5 criteria 
for delirium as the reference standard. The area under each curve (AUC) ranged 
from 0.89-0.94. The dot on each curve represents the published author-
described cut-point for that particular instrument. The DOSS is the only 
instrument where the author described cut-point occurs at Youden’s J statistic, 
which is considered the optimal cut-point to simultaneously maximize sensitivity 
and specificity. All the other author described cut-points appeared to prioritize 
specificity over sensitivity. This is further demonstrated in Table 4.2, which 
shows for each instrument the cut-point nearest to 90% sensitivity, the cut-point 
nearest to 90% specificity, the cut-point that maximizes Youden’s J statistic, and 
the author-described cut-point. The table presents the sensitivity and specificity 
at each cut-point. Additionally, the level on the latent trait, propensity to delirium, 
for each cut-point is shown. The latent trait is a continuous metric presumed to 
have a mean of 0 and standard deviation of 1. Importantly, we demonstrated that 
the latent trait level of 1 is the location on the metric that best describes case 
identification of delirium, since it yielded the cut-point that maximizes Youden’s J 




Figure 4.1. ROC curves for each delirium identification instrument 
compared to DSM-5 criteria 
 
 
CAM=Confusion Assessment Method, DOSS=Delirium Observation Screening 
Scale, DRS-R-98=Delirium Rating Scale-Revised-98, MDAS=Memorial Delirium 
Assessment Scale; AUC=area under the curve 
 
Figure legend: The receiver operating characteristic (ROC) curve for each of the 
instruments and their different scorings, plus the latent trait (propensity to 
delirium) is shown. Each curve displays the instrument AUC. The large dot on 
each curve is the author described cut-point on each instrument (except for the 
latent trait curve where the dot is Youden’s J statistic). The CAM short form and 





















Cut-point nearest to 90% sensitivity 
Cut-Point 2 5 2 6 12 10 1 
Sensitivity 89% 87% 92% 89% 89% 90% 91% 
Specificity 79% 82% 72% 79% 89% 89% 83% 
Latent Trait 0.86 0.94 0.56 0.80 1.17 1.15 -- 
        
Cut-point nearest to 90% specificity 
Cut-Point 3 7 5 9 13 10 1.25 
Sensitivity 69% 70% 63% 69% 84% 90% 81% 
Specificity 90% 90% 92% 91% 91% 89% 89% 
Latent Trait 1.55 1.36 1.52 1.38 1.31 1.15 -- 
        
Cut-point nearest to Youden's J-Statistic 
Cut-Point 2 5 3 6 11 8 1 
Sensitivity 89% 87% 85% 89% 93% 97% 91% 
Specificity 79% 82% 82% 79% 87% 82% 83% 
Latent Trait 0.86 0.94 0.98 0.80 1.05 0.89 -- 
        
Author described cut-point 
Cut-Point -- -- 3 13 17.75 15.25 -- 
Sensitivity 48% 48% 85% 27% 32% 31% -- 
Specificity 91% 91% 82% 96% 95% 95% -- 
Latent Trait -- -- 0.98 1.99 1.82 1.85 -- 
 
CAM=Confusion Assessment Method, DOSS=Delirium Observation Screening Scale, DRS-R-98=Delirium Rating 




In Table 4.3, each of the items across the four new example instruments is 
shown along with the source instrument of each item and the information of each 
item in descending order by information criteria. Example instrument 1 is a 
proposed short form that considered content validity, while example instrument 2 
did not, having unbalanced domain content. Example instrument 3 is a proposed 
long form that considered content validity and included one item per delirium 
identification domain. Example instrument 4 contains 10 items selected only on 
the basis of information at a latent trait level of 1 and without regard to content 
balancing across domains. If clinical utility gives primary consideration to 
instrument length, example instruments 1 and 2 would be favored. Thus, 
example instruments 1 and 2 (short forms) would be more appropriate for use in 
a clinical setting where rapid assessment is needed, and intended to be followed 
by more in-depth diagnostic assessment for confirmation. In situations where 
reliability or accuracy were the primary consideration, example instruments 3 and 
4 would be favored. Example instruments 3 and 4 could be best used for 
















at latent trait 
level of 1 
EXAMPLE INSTRUMENT #1 – short form with content validity 
Disorganized Thinking: rambling, irrelevant, or incoherent speech, or by 
tangential, circumstantial, or faulty reasoning 
MDAS 18.7 
Inattention: verbal perseverations, distractibility, and difficulty with set shifting DRS-R-98 2.5 
Acute onset: acute change in mental status from baseline CAM 1.6 
Disorientation and Cognitive Impairment: thinking he/she was somewhere 
other than the hospital, using the wrong bed, or misjudging the time of day CAM 1.4 
Fluctuating Course: symptoms come and go or increase and decrease in 
severity 
CAM 0.5 
EXAMPLE INSTRUMENT #2 – short form with highest information 
Disorganized Thinking: rambling, irrelevant, or incoherent speech, or by 
tangential, circumstantial, or faulty reasoning. 
MDAS 18.7 
Disorganized Thinking: disorganized or incoherent, such as rambling or 
irrelevant conversation, unclear or illogical flow of ideas, or unpredictable 
switching from subject to subject 
CAM 5.6 
Disorganized Thinking: abnormalities of thinking processes based on verbal 
or written output.  
DRS-R-98 5.6 
Inattention: verbal perseverations, distractibility, and difficulty with set shifting DRS-R-98 2.5 
Inattention: questions needing to be rephrased and/or repeated because 
patient's attention wanders, patient loses track, patient is distracted by outside 









EXAMPLE INSTRUMENT #3 – long form with content validity 
Disorganized Thinking: rambling, irrelevant, or incoherent speech, or by 
tangential, circumstantial, or faulty reasoning. 
MDAS 18.7 
Inattention: verbal perseverations, distractibility, and difficulty with set shifting 
difficulty 
DRS-R-98 2.5 
Acute onset: acute change in mental status from baseline CAM 1.6 
Disorientation and Cognitive Impairment: thinking he/she was somewhere 
other than the hospital, using the wrong bed, or misjudging the time of day 
CAM 1.4 
Hallucinations, perceptual disorder, or distortion: hallucinations, illusions, or 
misinterpretations 
CAM 0.99 
Cognitive Impairment: Short-term memory deficits DRS-R-98 0.85 
Fluctuating course: Fluctuation of symptom severity - waxing and waning of 
an individual or cluster of symptom(s) 
DRS-R-98 0.81 
Level of consciousness and Inattention: current awareness of and 
interaction with the environment 
MDAS 0.75 
Psychomotor agitation: picking, disorderly, restless DOSS 0.44 
Psychomotor retardation: reacts slowly to instructions DOSS 0.22 
EXAMPLE INSTRUMENT #4 – long form with highest information 
Disorganized Thinking: rambling, irrelevant, or incoherent speech, or by 
tangential, circumstantial, or faulty reasoning. 
MDAS 18.7 
Disorganized Thinking: disorganized or incoherent, such as rambling or 
irrelevant conversation, unclear or illogical flow of ideas, or unpredictable 
switching from subject to subject 
CAM 5.6 
Disorganized Thinking: abnormalities of thinking processes based on verbal 
or written output 
DRS-R-98 5.6 








Inattention: questions needing to be rephrased and/or repeated because 
patient's attention wanders, patient loses track, patient is distracted by outside 
stimuli or over-absorbed in a task 
MDAS 2.2 
Inattention: Maintains attention to conversation or action DOSS 1.9 
Acute onset: acute change in mental status from baseline CAM 1.6 
Acute onset: acuteness of onset of the initial symptoms of the disorder or 
episode being currently assessed 
DRS-R-98 1.4 
Disorientation and Cognitive Impairment: thinking he/she was somewhere 
other than the hospital, using the wrong bed, or misjudging the time of day 
CAM 1.4 
Inattention and Disorganized thinking: Does not finish question or answer DOSS 1.1 
 
CAM=Confusion Assessment Method, DOSS=Delirium Observation Screening Scale, DRS-R-





Table 4.4 shows sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) across each of the proposed example 
instruments. We show three cut-points for each instrument that could be used for 
different situations: screening, confirmation of diagnosis, and balanced high 
accuracy. The screening cut-point sought to maximize sensitivity (nearest to 
90%), while the confirmation of diagnosis cut-point maximized specificity (nearest 
to 90%), and the balanced high accuracy cut-point was at the level of the latent 
trait that maximizes Youden’s J statistic, each again with DSM-5 diagnostic 
criteria as the reference standard. Notably, the cut-point that optimized sensitivity 
and Youden’s J statistic was the same across each of the example instruments. 
Also, of note, each cut-point across each instrument demonstrated a generally 
high NPV, while PPV was low. Figure 4.2 shows ROC curves for each of the 
example instruments and for the latent trait, propensity to delirium, using DSM-5 
criteria for delirium as the reference standard. The area under each curve (AUC) 








Table 4.4. Psychometric properties of proposed new instruments 
New instruments derived from DEL-IB No. of Items Sensitivity Specificity PPV NPV 
Example instrument #1 (short form with content validity – score range: 0-10, AUC=0.91) 
Clinical Screening – optimize sensitivity (cut-point 3) 5 90% 81% 30% 99% 
Clinical Confirmation of Diagnosis – optimize specificity (cut-point 5) 5 66% 91% 40% 97% 
Clinical Balanced High Accuracy – Youden’s J statistic (cut-point 3) 5 90% 81% 30% 99% 
Example instrument #2 (short form with highest information – score range: 0-13, AUC=0.92) 
Clinical Screening – optimize sensitivity (cut-point 3) 5 92% 79% 29% 99% 
Clinical Confirmation of Diagnosis – optimize specificity (cut-point 6) 5 71% 91% 41% 98% 
Clinical Balanced High Accuracy – Youden’s J statistic (cut-point 3) 5 92% 79% 29% 99% 
Example instrument #3 (long form with content validity – score range: 0-21, AUC=0.92) 
Research Screening – optimize sensitivity (cut-point 6) 10 89% 83% 31% 99% 
Research Confirmation of Diagnosis – optimize specificity (cut-point 8) 10 76% 89% 39% 98% 
Research Balanced High Accuracy – Youden’s J statistic (cut-point 6) 10 89% 83% 31% 99% 
Example instrument #4 (long form with highest information – score range: 0-21, AUC=0.92) 
Research Screening – optimize sensitivity (cut-point 6) 10 89% 82% 32% 99% 







Research Balanced High Accuracy – Youden’s J statistic (cut-point 6) 10 89% 82% 32% 99% 
 
DEL-IB=Delirium Item Bank, PPV=positive predictive value; NPV=negative predictive value; 










Figure legend: The receiver operating characteristic (ROC) curve for each of the 
example instruments, plus the latent trait (propensity to delirium) is shown. Each 








This study provides a demonstration of the applications of an item bank, the 
DEL-IB, developed using advanced psychometric methods. First, we used the 
DEL-IB, that included items from the CAM, DOSS, DRS-R-98, and MDAS, to 
compare performance characteristics of these instruments. Next, we used the 
DEL-IB to create four new example instruments. The development and use of an 
item bank is highly novel in the field of delirium measurement research. Item 
banks have been used in educational testing for decades, but only recently have 
been applied in the field of measurement in healthcare. One recent advance in 
healthcare has been the use of modern methods in psychometrics to produce an 
item bank to fuel better measurement for patient-reported outcomes through the 
PROMIS (Patient-Reported Outcomes Measurement Information System) 
initiative (48). 
 
In this study, we identified potential cut-points that optimized either sensitivity or 
specificity, or for balancing both sensitivity and specificity simultaneously. 
Interestingly, in general the cut-point that each author had originally chosen for 
their instrument tended to fall far from the balanced cut-point chosen on the basis 
of Youden’s J statistic. The author-defined cut-points tended to have high 





Next, we used the DEL-IB to create new instruments and to evaluate their 
psychometric properties. While we had previously used the DEL-IB to create 
crosswalks between instruments [See Chapter III], the current work is another 
important demonstration of the usefulness of the DEL-IB. We displayed four 
example instruments, two short forms and two long forms, with one chosen to 
maximize content validity and the other to maximize psychometric information, 
respectively. We also recommended three separate cut-points that could be used 
on each instrument for different clinical or research purposes. Different 
customized instruments can be created to optimize clinical use across 
specialized settings and needs. For instance, screening tests would ideally be 
short-forms with high sensitivity; while diagnostic tests may be longer forms with 
high specificity. In settings with high prevalence of delirium, such as the intensive 
care unit, instruments with balanced accuracy may be preferred to minimize both 
false positives and false negatives. In the current study, it is key to note that 
while each cut-point had a high negative predictive value, they all had quite low 
positive predictive values. This means that if a participant were to test negative 
on any of the example instruments at any cut-point used, one could feel assured 
that they did not have delirium. However, if a participant were to test positive on 
any of the example instruments, further clinical evaluation would be required at 
any cut-point to confirm the diagnosis. Thus, these examples help to 
demonstrate how new psychometrically-based instruments can be developed 





The major strength of this study is that this is the only existing item bank for 
delirium identification instruments. The DEL-IB includes four different 
instruments, with a total of six different scoring methods, and 50 delirium 
assessment items. The DEL-IB was built from three international databases, 
which enhances generalizability. Another strength was the use of DSM-5-defined 
delirium diagnostic criteria as our reference standard, which is widely accepted 
as the current reference standard to evaluate the performance characteristics of 
each instrument. A further strength of this study stems from our previous expert 
panel work, which assessed each item and domain in DEL-IB for their content 
validity in delirium identification (8). This allowed us to easily select items across 
each domain vital to identifying delirium and the creation of example instruments 
that would uphold content validity. 
 
There are several limitations that deserve comment. First, the Adamis et al. 
dataset had a delirium prevalence that was lower than the other two studies. This 
is important to note since our simulations were based on extrapolating results of 
the Adamis et al. study to the dataset. However, we performed direct adjustment 
for this prevalence difference in our models, so this effect was minimized. While 
we are not aware of any problems, we must acknowledge that any potential 
errors or idiosyncratic features of the diagnostic procedure from Adamis et al. will 




delirium diagnostic criteria as our reference standard for the current study. 
However, it is essential to understand that the reference standard definition of 
delirium has evolved over time and will continue to do so, such that the 
instruments may perform differently based on which DSM reference standard 
was (or will be) used. Third, it should be noted that across the two example 
instruments that were created with only highest information considered, those 
examples are hindered by ‘bloated’ specific measurement. Bloated specific 
measurement refers to having instruments with too many items on a single 
domain of a construct, resulting in problems with content validity (27, 92). Fourth, 
the proposed instruments were developed as examples for using DEL-IB and are 
not intended for immediate clinical application. We did not consider the logistics 
of how to administer or order the items across the different example instruments. 
Refining and testing these instruments will be essential future work before these 
instruments—or any that are developed from the DEL-IB—are used in clinical 
practice. Fifth, it is a known problem in IRT that discrimination parameters can be 
biased upwards when maximum likelihood estimation procedures are used (93), 
as were used in this study. This can happen when trying to apply an IRT model 
to a set of items that are logically dependent upon one another, known as 
Guttman scales, e.g., difficulty carrying a 10-pound bag of groceries is logically 
dependent on difficulty carrying a 5-pound bag of groceries. This can also 
happen when items are de facto dependent upon one another because there is a 




use a parameter estimation technique that places constraints on the allowable 
range of parameter estimates, such as Bayesian parameter estimation. 
 
The creation of the DEL-IB is novel within the field of delirium research and has 
the potential to fundamentally advance the field. Based on our psychometric 
work, there is a potential case to be made that new cut-points may be 
appropriate on currently existing delirium identification instruments to aid in 
screening or diagnosing. Further investigation would be necessary to field test 
the proposed cut-points and new instruments in actual patient samples instead of 
simulated data. Field testing could also include examination of concurrent validity 
against DSM-5-defined delirium diagnosis as the reference standard and 
predictive validity against clinical outcomes. Additional next steps would include 
expanding on the DEL-IB by adding additional instruments from existing data 
sources with overlapping instruments. Ultimately, the goal is to find a single 
unified approach to identify delirium for the field and this work provides a 
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CHAPTER V – Discussion and Future Directions 
 
 
Restatement of Specific Aims 
The overarching goal of this dissertation project was to apply advanced 
psychometric methods to improve the identification of delirium. This project 
proceeded with the following specific aims. 
Specific Aim 1. Determine the 4 most commonly used and well-validated 
instruments for delirium identification through a systematic review of the 
medical literature, applying standardized methodologic quality ratings 
(Chapter II). 
Specific Aim 2. Harmonize the 4 most commonly used and well-validated 
delirium assessment instruments to generate an item bank, which is a 
collection of the individual instrument questions or ratings along with their 
parameter estimates derived from item response theory (IRT) analyses 
(Chapter III). 
Specific Aim 3. Explore applications of the harmonized item bank through 
several approaches. First, identifying different cut-points that will optimize: (a) 
balanced high accuracy (Youden’s J-Statistic), (b) screening (sensitivity), and 
(c) confirmation of diagnosis (specificity) in identification of delirium. Second, 
comparing performance characteristics of short forms (versus long forms) 




Summary of the Major Results 
In Chapter II, I reported on a systematic review and selection of high-quality 
delirium identification instruments. I conducted the systematic review by 
searching Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
Cochrane Library, Excerpta Medica Database (Embase), PsycINFO, PubMed, 
and Web of Science from January 1, 1974, to January 31, 2020, with the 
keywords “delirium” and “instruments,” along with their known synonyms. I 
identified 2,542 articles potentially pertaining to delirium measurement, and of 
these 75 met eligibility criteria for detailed review. The eligibility criteria included 
English-language articles only and requiring the article to be a systematic review, 
meta-analysis, or narrative review that evaluated at least two different delirium 
identification instruments. I excluded studies restricted to alcohol-related delirium 
(delirium tremens) or pediatric populations, studies using only animal models, 
studies in which delirium was not the outcome, or not a review article. These 
articles referenced 30 different delirium identification instruments. Two reviewers 
assessed the eligibility of articles and extracted data on all potential delirium 
identification instruments. The original publication of each instrument underwent 
methodologic quality review of psychometric properties using Consensus-based 
Standards for the Selection of Health Measurement Instruments (COSMIN) 
definitions. I convened a clinical expert panel that classified domains for delirium 
identification based on criteria from the Diagnostic and Statistical Manual of 




Scopus for the original publication of each instrument. Then, I undertook a 
methodological quality review of psychometric properties for each instrument 
using COSMIN definitions. Four instruments were noteworthy for having at least 
two of three of the following: citation count of 200 or more, strong validation 
methodology in their original publication, and fulfillment of DSM-5 criteria. These 
were, alphabetically, the Confusion Assessment Method (CAM), Delirium 
Observation Screening Scale (DOSS), Delirium Rating Scale-Revised-98 (DRS-
R-98), and Memorial Delirium Assessment Scale (MDAS). 
 
In Chapter III, I reported on the statistical harmonization of the four selected 
instruments identified in my systematic review (above). This chapter involved a 
secondary data analysis from three studies, and a simulation study based on the 
observed data. I obtained data from three previous studies of hospitalized older 
adults (age 65+ years) in the United States, Ireland, and Belgium. One of these 
studies (Ireland) (72), included reference standard diagnoses according to DSM-
5 criteria. The combined dataset included 600 participants, contributing 1,623 
delirium assessments. Each of the studies that generated the data assessed 
participants with multiple delirium identification instruments. Using item response 
theory (IRT), I linked scores across instruments, placing all four instruments and 
their separate scorings on the same metric (the propensity to delirium). Kappa 
statistics comparing agreement in delirium identification among the instruments 




MDAS. After linking scores, I created a harmonized item bank, called the 
Delirium Item Bank (DEL-IB), consisting of 50 items. The DEL-IB permitted me to 
create six crosswalks, which allow straightforward calculation of equivalent 
scores across instruments. 
 
In Chapter IV, I reported on applications of the DEL-IB to evaluate and create 
instruments, specifically to find optimal cut-points on the four instruments from 
Chapter III and to demonstrate use of the DEL-IB to create new instruments. I 
again utilized the combined international dataset of hospitalized older adults of 
600 participants introduced in Chapter III. I began by evaluating published cut-
points and establishing new cut-points (optimizing sensitivity or specificity, and 
Youden’s J statistic) on the latent trait, propensity to delirium, based on DSM-5-
defined delirium diagnosis from a reference standard collected in the Adamis et. 
al. dataset. For example, the cut-point on the MDAS at Youden’s J statistic was 
at a sum score of 6 with 89% sensitivity and 79% specificity. Then, I further 
explored the DEL-IB to create four example instruments (two short forms and two 
long forms) and evaluated their performance characteristics. The four example 
instruments illustrate differences when priority is given to brevity versus fidelity 
(short versus long) and when priority is given to sensitivity versus specificity 
(correctly identifying disease among those who truly have disease versus 
correctly ruling out disease among those who truly are disease free). These 




For example, clinicians may look to optimize sensitivity for the sake of screening, 
optimize specificity for diagnosing (especially when the next therapeutic step is 
very invasive like a brain biopsy), or apply findings to high-risk settings (i.e., 
intensive care units) with balanced accuracy. A short form optimized for 
sensitivity would be useful for quick screening in clinical settings, while a long 
form (with superior performance characteristics) could be used for more in-depth 
clinical interviews or research purposes. 
 
Products of this Work 
There are several major products of my work. From Chapter II, I have helped 
update the field by describing and characterizing the different delirium 
identification instruments in active use. I undertook a rigorous approach to 
comparing each of the instruments, resulting in our recommendation of the CAM, 
DOSS, DRS-R-98, and MDAS. Not only are these instruments widely used and 
demonstrate strong psychometric properties, but they are also fairly distinct in 
their target users and settings. For instance, the CAM was designed for use by 
non-psychiatrist clinicians and trained-lay raters. The DOSS was created for use 
by floor nurses. The DRS-R-98 and MDAS are typically used by trained 
psychiatrists. Thus, this study allowed us to identify instruments that would serve 
a broad swath of diverse users and patients, across multiple settings. This 
diversity of the instrument users and settings provided important context for 




useful across the field. Chapter III produced the Delirium Item Bank (DEL-IB), 
which yielded multiple applications and products. I created crosswalks that 
allowed for the direct comparison of scores across 6 different delirium 
identification instruments and scorings in real time. Currently, our team is 
developing a Harmonization Shiny App that will be accessed openly (without 
charge) through the NIH-funded Network for Investigation of Delirium: Unifying 
Scientists (NIDUS) website (94). The hope is that clinicians will use the app to 
compare scores at the time of care, and that researchers can use the app to 
compare and combine scores across patients and across studies in making 
group inferences. In Chapter IV, the DEL-IB was used to further understand the 
psychometric properties of selected delirium identification instruments from 
Chapter II. I offered different potential cut-points that optimized sensitivity, 
specificity or Youden’s J Statistic. I also compared the results to the author 
described cut-points. Additionally, I utilized the DEL-IB to create example short 
and long form instruments that one could use to accurately and rapidly identify 
delirium. I again suggested different potential cut-points that optimized sensitivity, 
specificity or Youden’s J Statistic, which one could need for different clinical or 
research circumstances. 
 
Major Conclusions of the Work 
There are several major conclusions and implications of this body of work. The 




improve measurement in the field of delirium. To achieve this goal, I applied 
state-of-the-art approaches of IRT, utilized in other fields of measurement, such 
as educational and psychological testing. I started with a systematic review of the 
existing medical literature to identify all of the current instruments in active use 
for identification of delirium, and selected key measures (based on a priori 
criteria) for my measurement work. Subsequently, I applied IRT approaches to 
harmonize the key measures I identified, which allowed me to statistically place 
them on the same metric, a latent trait called a propensity to delirium. Next, the 
IRT approaches also allowed me to create a delirium item bank (DEL-IB), which 
is a set of items (features of delirium) along with their parameter estimates, as a 
resource for the field. I demonstrated how to use the DEL-IB to create new 
measures to achieve different clinical goals (i.e., screening with maximal 
sensitivity, diagnosis with maximal specificity, or application to high-risk settings 
with balanced accuracy). Thus, this body of work provides the tools and methods 
to advance measurement in the field of delirium. In addition to the ability to create 
optimized measures for different settings and for different uses, these advances 
will allow for combination of data bases with harmonized outcomes; meta-
analytic studies; or generation of large data bases (such as for omics or machine 
learning studies). These new applications of my work hold substantial promise for 





Strengths of the Work 
Several strengths of this work deserve comment. I have updated the field of 
delirium by describing and characterizing the currently used delirium identification 
instruments and thoroughly investigating the psychometric properties of each 
instrument in its original publication. In Chapters II and IV, I convened an expert 
panel of interdisciplinary delirium clinical and research experts. This holds great 
value in assuring that the results of the work align with diagnostic criteria, and 
hold content and face validity. The development of the DEL-IB utilized a novel 
approach to the field of delirium by applying advanced psychometric methods to 
three independent datasets that each studied multiple and overlapping delirium 
identification instruments. A further strength is the fact that these datasets were 
multinational including older hospitalized patients from the United States, Ireland, 
and Belgium, which heightens the generalizability of the results. Importantly, the 
inclusion of DSM-5 reference standard ratings in the Adamis et al. dataset, which 
is considered the current reference standard for delirium identification, assisted in 
evaluating the instruments’ performance characteristics. Moreover, this is the first 
study in the field that I am aware of to use modern methods in psychometrics to 
harmonize 6 separate delirium identification instruments and their different 
scorings. The result of this work was the DEL-IB that is the only item bank in 





Caveats of the Conclusions 
There are caveats of the conclusions that require further discussion. In Chapter 
II, I utilized a systematic review of systematic reviews, which is an accepted 
approach. However, it is always possible that I may have missed some eligible 
studies and instruments. This is unlikely given the approach of reviewing the 
citations of the included articles and garnering input from experts in the field of 
delirium research. Restricting the psychometric review to the original publication 
of each instrument is another limitation, since it is possible that further 
investigation of the literature for validation studies for each instrument may have 
resulted in stronger psychometric evidence for each instrument. However, this 
would bias in favor of older instruments that have been in existence for a longer 
time, and therefore, may have had more validation studies published over time. 
The use of citation count could also bias towards older instruments, but this was 
only one of the selection criteria used by the expert panel. For the COSMIN 
rating, I only assessed the presence or absence of each of the validity or 
reliability criteria. The rankings of the instruments may have been different had I 
incorporated the actual performance statistics from the original publications. 
However, I decided not to use this approach since the studies used different 
reference standards, reported varying performance statistics, and examined 
disparate study samples of patients across diverse clinical settings. Additionally, 
since many patients in the intensive care unit (ICU) are non-verbal and the 




delirium identification instruments specific to the ICU setting. Unfortunately, this 
limits our ability to generalize my findings to the ICU setting. Further, I gave little 
consideration to distinguishing delirium in persons with underlying dementia. This 
is an aspect of the field of extreme importance that requires added future 
investigation. In future work, there will be a need to rank and rate delirium 
instruments for their ability to identify delirium superimposed on dementia or 
differentiate delirium and dementia. 
 
Another caveat is the lack of any primary data collection for the work in Chapters 
III and IV. Moreover, the existing secondary data sources may not have applied 
the instruments consistently or coded them the same way across all sites. Each 
of the samples came from hospitalized older patients, thus, the results may not 
be generalizable to non-hospital settings for delirium identification. The Better 
Assessment of Illness (BASIL) study is the largest known study of multiple 
delirium instruments applied to each participant. However, even after combining 
each of the three datasets together for a total of 600 participants, the overall 
sample size was limited for this type of work, and not every response category 
was seen across each instrument within participants. Thus, I utilized simulation 
methods to help draw our conclusions. I based the simulations on extrapolating 
results of the Adamis et al. dataset, which had a lower delirium prevalence than 
the other two studies. I accounted for this by performing direct adjustment for the 




potential limitation is that any inaccuracies in the assessment of DSM-5-defined 
delirium diagnosis procedures from Adamis et al. will be propagated into our 
simulation results. While I am not aware of any problems, I was not involved to 
assure high quality in the collection of the reference standard rating. A final 
limitation to mention is that the proposed example instruments developed from 
the DEL-IB are not ready for immediate clinical use at this time. There was little 
consideration given to the feasibility or logistics of administration of the 
instruments, or ordering of the items across the example instruments. The next 
steps would include refining and testing these instruments (or any other potential 
instruments developed from the DEL-IB) in a field study of patients to assure 
their feasibility and validity before application in clinical practice. 
 
Implications of the Work and Future Directions 
There are many implications of this work and future directions that research in 
the field of delirium should take. The major implication of this work leads directly 
to help interpret and combine current delirium studies, and help with developing 
new measures using the DEL-IB. In a future step, I could continue to expand the 
DEL-IB with additional existing studies that have another delirium instrument and 
one of CAM, DOSS, MDAS, DRS-R-98 or studies that have one of these 
instruments to help with the calibration by adding a greater sample size (i.e., a 
study with 1000 participants all only assessed by the DOSS). Currently, the 




utilized to help expand the DEL-IB, and ultimately combined for meta-analyses or 
integrative analyses of pooled data. Another future direction to undertake would 
include validation of the derived example short and long forms from Chapter IV in 
a prospective multicenter cohort study. I could also mount integrative data 
analysis using one of four instruments to have directly comparable outcome 
measures across studies. Another major step includes the creation of big 
datasets. These could be synthesized via meta-analyses or integrative analysis 
for many potential uses. For example, the synthesis of results from multiple 
clinical trials could directly inform treatment recommendations, and assist with 
development of clinical guidelines and clinical practice standards. This kind of 
work has already been seen in the field of delirium with a recent systematic 
review on the risks of antipsychotic use for delirium, where outcomes were 
utilized across studies to draw conclusions and make recommendations (95). 
“Big data” is also needed for omics studies (e.g., genomics, proteomics, 
metabolomics, etc.) that advance the understanding of pathophysiology, which 
currently is poorly understood in delirium. Big data can further be applied to 
population-based prediction models that require large datasets, such as, 
machine learning or advanced prediction approaches. Item banks have been 
used for computerized adaptive testing (CAT), which enables the development of 
streamlined approaches for diagnosis (96). With a large enough item bank, and 
with enough participants, someday it may be possible that the DEL-IB could be 




settings. Ultimately, this dissertation lays the groundwork for many future 
directions in the field of delirium research and clinical care. 
 
Unexpected Results and Personal Reflection 
There were a number of unexpected results and important lessons that I learned 
along this journey. I learned how to perform and finish a systematic review from 
start to finish, which turned out to be much more time-consuming than I 
envisioned in the beginning of my thesis work. I learned the value of collaborating 
with other groups with similar interests, who were able and willing to share data. 
However, the task of understanding the different data sets and sorting them was 
arduous and intensive to find the proper data for the needs of this dissertation 
work. I gained expertise in measurement, psychometrics, and test development, 
which on top of my pre-existing knowledge of epidemiology are skills that I now 
realize will ultimately translate to any field I decide to pursue. I did not fully grasp 
all of the potential uses for an item bank and the large number of applications 
that have real-world practical value, i.e., harmonization, crosswalks, and creation 
of new instruments. The DEL-IB could be enriched further with a large number of 
additional items across all delirium identification instruments. This was the first 
study I undertook using simulation methods. I discovered how I can use 
simulation to help solve many complex problems and can extrapolate to many 
other situations. I learned to be flexible in my scientific approach and managing 




unexpectedly. These unexpected discoveries often lead to a need to adapt and 
adjust one’s thoughts and timeline. Additionally, the COVID-19 pandemic 
changed the entire global landscape and my day-to-day work on my dissertation, 
and I had to adapt and persevere. I have also learned about grant writing and the 
entire National Institutes of Health (NIH) application process by writing an R36 
grant to support my dissertation work, which was successfully funded. 
 
 
Influence on Future Career Directions 
I believe the work on this dissertation will influence and impact my future career 
in many tangible and intangible ways. I have truly gained an appreciation for 
rigorous scientific discovery, and I see myself as an academic physician scientist 
moving forward. I have learned how to think critically about evidence and how to 
problem solve skillfully. The field of measurement, epidemiology, and public 
health will pertain to any biomedical field and I see myself continuing in related 
research, applying measurement techniques I have learned to other topics in the 
field of medicine I choose for my career. As for the next steps in my career, I am 
planning to pursue a residency in internal medicine. While I do not yet know what 
specific fellowship I would wish to pursue, I do know I will continue to hold a 
strong interest in aging, epidemiologic, and measurement research, and I hope to 
build on these areas and strengths moving forward. I am confident that this 
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